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ABSTRACT 
Oligodendrocytes (OLs) are specialized glial cells of the central nervous system (CNS) 
responsible of myelin formation and trophic support of neurons. The understanding of mechanisms 
regulating OL differentiation may have fundamental implications in the development of therapeutic 
strategies for demyelinating and neurological diseases. In this respect, the G protein-coupled 
receptor 17 (GPR17) is considered a promising pharmacological target, in the light of its well-
established role in the regulation of OL differentiation by acting as an intrinsic timer of the process. 
GPR17 is specifically and transiently expressed by a subset of NG2-positive OL precursors (OPCs) 
that exit mitosis and undergo cell differentiation. However, GPR17 expression has to be down-
regulated before cells enter the terminal myelinating phases. Despite the many efforts that were 
made, the mechanisms controlling GPR17 expression are still unclear. To shed light on these 
mechanisms we have focused on the control of GPR17 intracellular trafficking. A process that 
regulates GPR17 levels at the cell surface and also its global expression. Our previous 
characterization of GPR17 endocytic trafficking had shown that upon endocytosis GPR17 is 
subjected to endosomal sorting between lysosomal degradation or recycling via the short loop 
pathway. In the light of this observation we decided to understand the molecular machineries that 
regulate GPR17 endosomal sorting. We here have demonstrated that the PDZ-binding motif 
expressed at GPR17 C-terminal is fundamental for receptor recycling, by mediating an interaction 
of GPR17 with SNX27. SNX27 is an accessory protein of the retromer complex that is emerging as 
a master regulator of receptor short loop recycling. We observed that loss of SNX27 unbalances 
GPR17 endosomal sorting and determines an increased receptor degradation and down-regulation. 
Interestingly, GPR17 precocious down-regulation was accompanied by an increased expression of 
myelin proteins, indicating an accelerated kinetics of OL differentiation in SNX27-silenced 
samples. Notably, we also found decreased GPR17 expression levels in Ts65Dn mouse brains, 
which are characterized by decreased levels of SNX27. Ts65Dn mice are the most used murine 
model of Down syndrome (DS). In accordance with what observed for DS patients, we found also a 
reduced amount of myelin fibers in Ts65Dn brains. The mechanism underlying myelination defects 
in DS brain is unknown. On the basis of the observation that SNX27 down-regulation was 
determined by reduced levels of C/EBPβ transcription factor, which are due to overexpression of 
trisomic micro-RNA 155 (mir-155), we decided to better characterize the role of mir-155 in OLs. 
Our preliminary results indicated that mir-155 is expressed at low levels in the oligodendroglial 
lineage and that its overexpression (mimicking pathological condition) determines a sustained 
inhibition of OL differentiation. This effect, however, is not dependent on SNX27 down-regulation, 
suggesting that other mechanisms may be involved. 
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RIASSUNTO 
Gli oligodendrociti sono un particolare tipo di cellula gliale del sistema nervoso centrale, 
responsabile della formazione della guaina mielinica e di fornire supporto trofico per i neuroni. La 
comprensione dei meccanismi che ne regolano il differenziamento è di fondamentale importanza 
per lo sviluppo di strategie terapeutiche per malattie demielinizzanti e neurologiche. In questo 
senso, GPR17, un recettore associato a proteina G, è considerato un promettente target 
farmacologico, sulla base del suo ruolo ben stabilito di timer intrinseco del differenziamento degli 
oligodendrociti. GPR17 è espresso in maniera specifica e transiente da un sottogruppo, NG2-
positivo, di precursori degli oligodendrociti, i quali escono dalla mitosi e incominciano a 
differenziarsi. Tuttavia, l’espressione di GPR17 deve essere down-regolata prima che le cellule 
entrino nelle fasi finali di mielinizzazione. Nonostante i numerosi sforzi che sono stati compiuti, i 
meccanismi che regolano l’espressione di GPR17 non sono ancora del tutto conosciuti. Per 
comprendere meglio questo aspetto, ci siamo concentrati sui meccanismi che ne controllano il 
traffico intracellulare, un processo importante per la regolazione sia dei livelli di recettore esposti 
alla superficie cellulare, che di quelli globali. La nostra iniziale caratterizzazione del traffico 
endocitotico del recettore, ci ha permesso di rivelare che, dopo endocitosi, GPR17 è sottoposto a un 
processo di smistamento tra degradazione a livello lisosomiale e riciclo in membrana. Sulla base di 
queste osservazioni, abbiamo quindi deciso di studiare i meccanismi molecolari che regolano tale 
smistamento endosomiale. In questo lavoro abbiamo dimostrato che il “PDZ-binding motif” 
espresso al C-terminale di GPR17, è essenziale per il riciclo del recettore, poiché permette 
un’interazione con SNX27. SNX27 è una proteina accessoria del complesso del retromero, che 
negli ultimi anni sta emergendo come il principale regolatore del riciclo recettoriale attraverso la via 
di riciclo rapido. Abbiamo inoltre osservato che in assenza di SNX27 lo smistamento endosomiale 
di GPR17 è sbilanciato, e si ha una maggiore degradazione e down-regolazione del recettore. 
Questa prematura down-regolazione di GPR17 è accompagnata da un aumento nell’espressione di 
alcune proteine della mielina, indicando un’accelerazione nella cinetica di differenziamento degli 
oligodendrociti nei campioni silenziati per SNX27. Inoltre, abbiamo individuato un ridotto numero 
di cellule GPR17-positive in cervelli di topi Ts65Dn, che sono caratterizzati da una riduzione 
nell’espressione di SNX27. I topi Ts65Dn sono il modello murino più utilizzato per studiare la 
sindrome di Down. In analogia con quanto osservato nei pazienti Down, abbiamo individuato una 
ridotta presenza di fibre mieliniche nei cervelli di tali topi. I meccanismi alla base di ciò sono 
sconosciuti. Per chiarire meglio tali meccanismi, abbiamo quindi deciso di iniziare a caratterizzare 
il ruolo del micro-RNA 155 negli oligodendrociti, sulla base del fatto che la down-regolazione di 
SNX27 è determinata da una diminuzione del fattore di trascrizione C/EBPβ, a sua volta dovuta alla 
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sovra-espressione del micro-RNA 155 (trisomico). I nostri risultati preliminari indicano che il 
micro-RNA 155 è espresso a bassi livelli negli oligodendrociti, e che la sua sovra-espressione 
(mimando le condizioni patologiche) determina una forte inibizione del differenziamento 
oligodendrocitario. Questi effetti, tuttavia, non sembrano dipendere dalla down-regolazione di 
SNX27, suggerendo che altri meccanismi potrebbero essere coinvolti. 
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INTRODUCTION 
OLs are a specialized type of glial cell of the CNS. OLs are responsible of a number of 
different functions. They produce myelin, a multi-layered compact sheath that surrounds axons and 
allows action potential saltatory conduction. Moreover, they physically and metabolically sustain 
neurons. Given the roles that OLs hold, it is easy to understand why their degeneration or 
disregulation affect the physiological functioning of CNS, leading to pathological conditions. In 
particular, OL degeneration is the main etiology of pathologies that for this reason are collectively 
referred to as demyelinating diseases of the CNS and include leukodystrophic disorders and the 
most known multiple sclerosis (MS). OL disregulation on the other side is now reported for a 
number of different neurological and psychiatric disorders such as autism, DS, schizophrenia and 
depression among the others (Fields, 2008). 
Myelinating OLs derive from the differentiation of OPCs. Interestingly, OPCs are still 
present in the adult brain, scattered in the different brain areas either in the white or in the grey 
matter. Adult brain OPCs are arrested in a quiescent state but, differently from neuronal precursors, 
their activation has been described in response to stimuli such as brain injuries and ischemia. The 
fundamental implication of these observations is that if we learn how to promote and control adult 
brain OPC development, a strategy arises for the treatment of pathologies where OL physiological 
functioning is compromised. 
The first step to understand how OL differentiation is modified in response to pathologies is 
to characterize in details the mechanisms that physiologically underlie and regulate their 
development. 
 
From immature precursors to myelinating cells: factors that regulate 
OL development 
The majority of OLs present in the adult brain derives from specification and differentiation 
of neural precursor cells (NPCs) of the neural tube. OL development is a highly specialized process, 
temporally and spatially restricted, finely tuned with the development of the CNS. It can be 
basically divided into three phases: firstly, NPCs are committed towards oligodendroglial lineage 
(OPC specification); secondly, OPCs proliferate and spread in the developing brain (OPC 
proliferation and migration); finally, immature cells differentiate giving rise to mature OLs able, 
when get contacts with neurons, to produce myelin and wrap neuronal axons (Emery, 2010) 
(Intro.Fig. 1). 
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Myelination is a late-occurring process. Furthermore, the time period over which it occurs is 
long too. OPC development begins nearly at embryonic days 12-13 in mice (embryonic week 5 for 
humans) and continues after birth until the first two weeks (first two months for humans), with 
evidences of de novo synthesis and remodeling also during adulthood (Mitew et at., 2014). 
OPCs originate, proliferate and migrate from specific germinal niches, and the process 
occurs in three sequential waves. The first precursors are formed at around E12.5 (in mice) in the 
ventral neural tube, specifically in the medial ganglionic eminence (MGE, Intro.Fig. 1A) and the 
closely associated enteropeduncular area (AEP, Intro.Fig. 1A). Ventrally-derived OPCs spread to 
most of the developing telencephalon until E18, when the majority is surrounded and replaced by a 
second wave of dorsally-derived OPCs, originating in the lateral and caudal ganglionic eminences 
(LGE/CGE, Intro.Fig. 1A). A final third wave of OPCs begins after birth from cortical progenitor 
cells (Richardson et al., 2006; Lopez Juarez et al., 2016). Some studies suggested that adult-brain 
OPCs mainly derive from NPCs located in the subventricular zone of the lateral ventricles (Zuchero 
and Barres, 2013). Interestingly, it was reported that the genetic ablation of either ventral or dorsal-
derived OPCs results in a compensatory effect of the counterpart-derived precursors that leads to a 
normal final complement of OLs and myelin (Mayoral and Chan, 2016). 
 
 
Intro. Figure 1. Schematic representation of the different phases of OL development. 
A The first wave of OPCs originates from NPCs localized in the AEP and VGE areas of the ventral 
neural tube at E12.5. They are then surrounded and replaced by a second wave of precursor cells 
that originates in the LGE, a more dorsal area compared to AEP and VGE. B After migration OPCs 
undergo through different phases of differentiation to become mature myelinating OLs. The 
expression windows of GPR17 and of some intrinsic TFs involved in OL differentiation regulation 
are reported. Figure is adapted from Somkuvar et al., 2014 and Traiffort et al., 2016. 
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After specification OPCs undergo to different phases of maturation from precursors to pre-
myelinating and myelinating OLs and a number of different factors attend at the regulation of OL 
differentiation (Intro.Fig.1B). They are basically divided in extrinsic and intrinsic factors. The 
impact of extrinsic and intrinsic factors and whether OL development is essentially driven by 
extracellular signals, internal controls or a combination of the two is still object of discussion. An 
important consideration is that studies of gene expression profiling revealed a high grade of 
heterogeneity in the gene expression pattern of OPC populations derived from different brain areas, 
suggesting that intrinsic differences may guide OPC development. However, it is still not resolved 
whether this diversity depends on either a differential genetic commitment of OPCs or different 
maturation stages and/or different external cues (Mayoral and Chan, 2016). It is also unresolved 
whether distinct sub-populations of precursor cells originate specialized OL subtypes with peculiar 
molecular and/or functional properties (Zuchero and Barres, 2013). 
 
Among the factors described to regulate OL development, many have multiple (and 
sometimes contrasting) roles over the subsequent phases of the process. Since it is not aim of this 
introduction to describe all the mechanisms underlying OL development (please refer to reviews He 
and Lu, 2013; Mitew et al., 2014), while it is thought to contextualize our experimental work in the 
complexity of myelination, I will describe the many aspects that concur to the complex scenario of 
OL development, focusing on factors whose roles are more established. In doing this, I will firstly 
summarize intrinsic controls of OL maturation, describing in a second part how external signals 
modify OL development by acting on intrinsic regulator activity. 
 
Intrinsic factors 
All the most important transcription factors (TFs) involved in OL development belong to the 
basic-helix-loop-helix (bHLH) superfamily. Among them OLIG1, NKX2.2, SOX10, TFC4 and 
ASCL1 are known to be positive regulators of OL development, while Id2, Id4, HES5 and SOX6 
are well-established inhibitors of maturation (Emery, 2010). However, the most characterized TF 
involved in the promotion of OL development is OLIG2. Although its expression is reported also in 
precursors of motor neurons, OLIG2 is a reliable marker of the oligodendroglial lineage, and is 
expressed at all the stages of the development. Accordingly, OLIG2 functions span the whole 
process of OL maturation, and OLIG2 is probably the master TF onto which convey signaling 
pathways of external cues. The knockout of the gene determines a failure of OPC generation, while 
OLIG2 overexpression in NPCs forces cell specification towards OPCs (Lu et al., 2002). Different 
strategies were reported to regulate OLIG2 activity. As for many other TFs, enhancers and 
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inhibitors influence OLIG2-dependent transcription. In addition, Id2 and Id4 (inhibitor of DNA 
binding proteins 2 and 4) were shown to directly bind OLIG2, blocking DNA transcription. 
Furthermore, OLIG2 activity was suggested to depend on phosphorylation. In particular, some 
studies proposed that different oligodendrogenic pathways might merge their signaling on the 
regulation of OLIG2 phosphorylation state (Mitew et al., 2014). Once activated, OLIG2 may 
directly promote gene transcription, while some studies suggest that it exerts its functions also by 
recruiting chromatin-remodeling factors such as SMARCA4/BRG1 (Zuchero and Barres, 2013). In 
addition to OLIG2, another TF shown to promote myelination is OLIG1. In particular OLIG1 is 
thought to regulate the terminal myelination of differentiating OLs, due to observation that OLIG1-
knockout mice express early OLs with complex branched-shapes that fail to myelinate (Xin et al., 
2005). Despite this observation, the mechanism by which OLIG1 exerts its functions is unclear. It 
has been shown that OLIG1 re-localizes from nucleus to cytosol in coincidence with myelination 
beginning. Whether this translocation is required for the recruitment of promoter factors present in 
the cytosol, or for the removal of inhibitory factors is still unresolved (Mitew et al., 2014). OLIG1 
was proposed to co-operate with SOX10, a TF shown to control the expression of a number of 
genes tightly correlated to myelin formation and among them MBP promoter activity. In 
accordance, OLs are arrested in a pre-myelinating stage in SOX10 conditional-null mice (Li et al., 
2007). 
Other important TFs involved in OL myelination promotion are: NKX2.2, MYRF (MRF; 
myelin gene regulatory factor) and ZFP488 (He and Lu, 2013; Mitew et al., 2014). 
Concerning inhibitory intrinsic controls of OL development, well established is the role of 
Id2 and Id4. During OL differentiation Id2 and Id4 are activated by many different signals among 
which are BMP/SMAD signaling pathway, GPR17 signaling, and Wnt/β-catenin. Once activated 
Id2 and Id4 conformations change leading to their translocation from cytosol to nucleus where 
Id2/Id4 directly regulate gene transcription and also inhibit OLIG2 activity (Chen et al., 2009). In 
addition to Id2/Id4 OL maturation is under the negative control of HES1 and HES5. These TFs are 
activated downstream to the NOTCH signaling pathway and act directly as TF but also by 
inhibiting SOX10 (Wang et al., 1998). 
A number of studies were conducted to decipher the role of TFC4/TCF7L2 complex, which 
mediates the effects of Wnt/β-catenin signaling pathway. Although some aspects are still unclear, it 
is now accepted that the complex has a dual role in OL differentiation. In accordance with the 
Wnt/β-catenin signaling, TFC4/TCF7L2 are transiently activated during OL differentiation: while 
their activation arises at the onset of the process, their signaling requires to be down-regulated 
before terminal differentiation, otherwise myelination fails. TFC4/TCF7L2 were shown to activate 
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a number of inhibitory genes, including Id2. Surprisingly, however, TCF4 knockout was shown to 
arrest myelination (He and Lu, 2013). 
Interestingly, despite the number of intrinsic mechanisms controlling OL development, no 
one of the listed factors appears to be essential. This conclusion is suggested by the observation that 
knocking-out each of the above described TFs does not completely abolish OL development. Thus, 
we may assume that mechanisms underlying OL development are highly intertwined and redundant. 
 
External cues 
A number of different external cues have been implicated in guiding OL maturation in the 
complex scenario of CNS development. 
 
OPCs are generated by a progressive specification of NPCs present in specific germinal 
niches. An important cue described to drive ventrally-derived OPC specification is sonic hedgehog 
(SHH), which acts by means of different intracellular pathways. SHH activates NKX6.1 and 
NKX6.2 TFs that, in turn, promote the OLIG2-dependent expression of genes involved in NPC 
commitment towards OPCs. In addition, SHH favors the formation of GLI1/2 complex and 
counteracts GLI3 repressor activity, thus finally leading to the activation of OLIG2 (He and Lu, 
2013). Notably, the floor plate and the notochord specifically secrete SHH to drive the formation of 
ventrally-derived OPCs, and the ectopic grafting of SHH-expressing tissue results in the generation 
of ectopic OPCs (Yu et al., 2013). Dorsally-derived OPCs are too far to sense the SHH-driving 
signal. This observation suggested that other factors might also be involved in OPC specification. 
Accordingly, Bone Morphogenic Protein (BMP)/SMAD and Wnt/β-catenin signaling pathways 
were also shown to regulate OPC generation, although with inhibitory roles (Richardson et al., 
2006). BMP is a family of growth factors that belong to the TGFβ superfamily. BMP signaling is 
mediated by the SMAD complex, which is composed by SMAD1/SMAD5/SMAD8 proteins. Once 
activated the SMAD complex leads to an increased expression of Id2 and Id4, which, as previously 
reported, negatively regulate OL differentiation (He and Lu, 2013). The FGF family of proteins also 
plays important roles in OL development. In particular, during the different phases of OL 
development FGF-2, FGF-8, FGF-17 and FGF-18 were shown to control many and differential 
aspects. FGFs act on specific receptors (FGFRs) expressed on developing OPC cell surface. The 
ERK1/2 (extracellular signal-regulated kinases 1 and 2) and MAPK signaling pathways are then 
activated downstream to FGFR stimulation. With specific regards to OPC specification, FGF-2 was 
shown to promote OLIG2 activity, via activation of ERK1/ERK2 pathway (He and Lu, 2013; 
Mitew et al., 2014). 
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Committed OPCs, before differentiate into mature myelinating cells, spread in the whole 
brain areas. In doing this, OPCs undergo a process of proliferation and migration. It is interesting to 
note that migration and proliferation are commonly considered pathways alternative to OPC 
differentiation. By proliferating and migrating, OPCs populate different brain areas with immature 
cells, whose differentiation will be context-dependent and driven by environmental-specific cues. It 
is indeed commonly accepted that mitogens and motility-promoting factors have also anti-
differentiating properties, while, on the contrary, promoters of OPC differentiation also determine 
cell exit from mitosis (Mayoral and Chan, 2016). A master regulator of OPC proliferation is PDGF-
AA (platelet derived growth factor-AA) by acting on its receptor PDGFRα. Once engaged by 
PDGF-AA, PDGFRα seems to activate many intracellular pathways, including MAPK signaling 
cascade, phospholipase C gamma (PLCγ) and the PI3K/AKT signaling pathways (He and Lu, 
2013). FGF-2 in addition to promote OPC specification was also reported to sustain cell 
proliferation by working in concert with IGF-1 to activate cyclinD1 (He and Lu, 2013). OPC 
survival is also increased by neuregulin-1 (NRG-1), which is either expressed on the surface of 
neurons or secreted as an extracellular peptide. NRG-1 acts by activating PI3K/AKT pathway by 
means of activation of ERB B tyrosine-kinase receptor, expressed on OPC cell membranes. 
 
Three categories of molecules drive OPC migration: chemokinetic secreted molecules, 
chemotactic cues present in the extracellular matrix, and contact molecules expressed on the surface 
of developing neurons and glial cells. The most important chemokinetic cues are the already 
described PDFG-AA and FGF-2 (Mitew et al., 2014). In addition to these, molecules of the 
extracellular matrix play a very important role. Among them are laminins (in particular laminin-2), 
fibronectins, merosin, tenascin and anosmin-1. These molecules are mainly sensed by integrins 
expressed on the surface of migrating OPCs and a particularly relevant role has integrin α6β1 (He 
and Lu, 2013). Finally, with regards to adhesion molecules expressed on cell surface by OPCs and 
other cell types, PSA-NCAM, ephrins, NG2 and N-chaderins have all been associated to the control 
OPC migration. Notably, contact sites between OPC themselves are thought to regulate cell 
migration so that the final result would be a homogeneous distribution of cells in brain parenchyma 
(Mitew et al., 2014). 
 
Among the phases that OLs tread during their development, the terminal differentiation is 
probably the most characterized and studied. This is due to the implications that OL differentiation 
control may have for the development of strategies to contrast demyelinating diseases and to 
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promote recovery of myelin degeneration. A number of mechanisms are now well established to 
exert regulatory effects on differentiation process. Interestingly, many of these mechanisms have 
inhibitory effects. Among these are the LINGO1/NOGO signaling axis and NOTCH signaling 
pathway (Emery, 2010). LINGO1 is expressed by both neuronal axons and adjacent differentiating 
OLs and binds NOGO receptor on OL cell surface. It exerts its inhibitory functions by decreasing 
the activity of FYN kinase, which, consequently, increases RHOA activity leading to anti-
differentiating effects (Mitew et al., 2014). NOTCH signaling is also activated by neuronal 
expression of JAGGED1 and DELTA1 ligands. OPCs express both NOTCH1/NOTCH2/NOTCH3 
receptors (He and Lu, 2013). NOTCH1 activation upon ligand-binding is the best characterized 
pathway, which was demonstrated to determine the cleavage of NOTCH cytoplasmic tail, thus 
leading to the release of a soluble peptide (NICD), that enters the nucleus and promotes the 
expression of HES1 and HES5 TFs. As previously reported, HES1 and HES5 are well-characterized 
negative regulators of OPC differentiation (Mitew et al., 2014). 
The Wnt/β-catenin signaling pathway is also one of the most studied mechanisms 
underlying OPC differentiation. As described previously, Wnt/β-catenin effects are mediated by 
TCF4/TCF7L2 TFs (He and Lu, 2013). It is now thought that Wnt signaling may promote the initial 
differentiation stages but it must be shut down before OL terminal myelination (Emery et al., 2010). 
BMP and FGF families, which were both described to be important for the control of OPC 
specification, also concur to the negative regulation of differentiation process (He and Lu, 2013). 
Among FGF family members FGF-8, FGF-17 and FGF-18 inhibit OPC differentiation, while FGF-
9 enhances differentiating OPC ramification and processes extension (He and Lu, 2013). 
Few signals have been reported to sustain OL differentiation. Among them a very relevant 
role has triiodothyronine (T3) hormone. Even if not essential for the developmental process, T3 
seems to be particularly important for the correct timing of OL maturation. Consistent with this 
hypothesis, congenital hypothyroidism patients have defective myelination while hyperthyroidism 
determines precocious myelination and an elevated number of mature OLs (Mitew et al., 2014). 
 
As well as for OL differentiation, the majority of extracellular signals identified to date as 
regulators of OL myelination are inhibitory. Thus, they are deputed at preventing myelination of 
wrong axons or excessive myelination. The already mentioned axonal molecules PSA-NCAM, 
JAGGED1 and LINGO1 are well-characterized examples. On the contrary, examples of pro-
myelinating factors are laminin-β2 and NRG-1. Laminin-β2 is expressed by neurons just before 
being myelinated and binds to β1-integrin expressed by OLs. NRG-1, by binding ERB B3 on OL 
membranes, was proposed to be important for both the regulation of myelin thickness and for 
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myelin remodeling process that occurs in the postnatal period (and also in adulthood) (Zuchero and 
Barres, 2013). All these extracellular signals finally converge on the modification of actin 
cytoskeleton. In particular, many downstream signaling pathways involve the activation of FYN 
kinase that results in the inhibition of anti-differentiation factor RHOA (Wolf et al., 2001). This 
observation suggests FYN/RHOA pathway as a possible general effector of myelination process 
(Mitew et al., 2014). 
 
Neuronal activity 
Neuronal activity was largely described to control OL differentiation and myelination. 
Different mechanisms have been proposed to explain the observed effects. A first possibility is that 
electrical activity may regulate the expression of cell surface ligands on neuronal axons. In addition, 
active neurons may release adenosine in the extracellular matrix, thus acting on purinergic 
receptors, known to be expressed by OLs (Emery, 2010). It has also been proposed that OPCs may 
form functional synapses regulated by neuronal activity. In this respect it is important to note that 
OLs express both ionotropic glutamate receptors (α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptor, AMPA; and N-methyl-D-aspartate receptor, NMDA) and voltage-
gated ion channels that may be directly stimulated by glutamate secreted by neuronal synapses (De 
Biase et al., 2010). However, the exact role of AMPA and NMDA receptors in OL differentiation 
and whether their stimulation is a pro- or anti- differentiating cue is still controversial (De Biase et 
al., 2011). Despite are still incompletely resolved the molecular mechanisms it is mediated by, OL 
differentiation and myelination driven by neuronal activity is an interesting candidate suggested to 
exert an important role in the regulation of OL remodeling and plasticity associated to learning 
(Zuchero and Barres, 2013). 
 
Epigenetic mechanisms 
The role of epigenetic mechanisms is starting to be studied in the context of OL 
development. Chromatin remodeling hystone acetylase and deacetylase (HDAC) family members 1 
and 2 (HADAC1 and HADAC2) were reported to act upstream and regulate Wnt/β-catenin 
signaling pathway (Ye et al., 2009). Furthermore, SWI/SNF and SMARCA4/BRG1 are examples of 
ATP-dependent chromatin remodeling complexes which control transcription of genes associated to 
OL development by regulating hystone positioning (Emery, 2010). Few is known regarding micro-
RNA involvement in the regulation of OL maturation. Functions have been proposed for mir-219, 
mir-338, mir-7a and mir-125-3p (Duglas et al., 2010; Zhao et al., 2010; Lecca et al., 2016). 
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Slow and steady wins the race, an intrinsic timer for OL development: 
GPR17 
In 2006 Ciana and colleagues described for the first time the pharmacological properties of a 
G protein-coupled receptor with an intermediate phylogenetic position between P2Y and CysLT 
receptor families: GPR17 (Ciana et al., 2006). A growing number of studies indicate that GPR17 is 
transiently expressed during OL differentiation and may have opposite stage-specific roles: a 
positive function in the early phase of OPC differentiation and a negative role in pre-myelinating 
OLs (Ceruti et al. 2009; Chen et al., 2009; Boda et al., 2011; Fumagalli et al., 2011; Fratangeli et al. 
2013, Hennen et al., 2013, Viganò et al., 2016). In myelin lesions associated to MS, stroke and stab 
wound injuries an abnormal overexpression of GPR17 was described in OPCs that surround myelin 
degeneration. These GPR17-expressing cells are arrested in a quiescent state and fail to repair 
myelin defects (Lecca et al., 2008; Chen et al., 2009; Boda et al., 2011). The down-regulation of 
GPR17 was proposed to force quiescent OPCs to overcome differentiation arrest and complete their 
maturation (Hennen et al., 2013; Simon et al., 2016). On the other hand, GPR17 stimulation could 
also be useful for promoting OL differentiation (Lecca et al., 2008; Fumagalli et al., 2011; Daniele 
et al., 2014; Fumagalli et al., 2015). For these reasons GPR17 is a putative (and promising) 
pharmacological target for the treatment of demyelinating diseases and MS in particular (Ceruti et 
al., 2009; Boda et al., 2011). 
 
Although GPR17 is mainly studied in the oligodendroglial lineage, it is also expressed at 
lower levels by neurons and, under specific conditions, also by microglia. Moreover, its expression 
was confirmed in heart and kidney, while the transcript was found in lung and liver (Ciana et al., 
2006). With regards to OLs, GPR17 decorates a specific subset of NG2-positive precursor cells that 
under physiological conditions are scattered in the brain parenchyma both in the white and in the 
grey matter (Ceruti et al., 2009; Boda et al., 2011). GPR17-expressing cells could also be found in 
typical neurogenetic areas such as hippocampus, ependymal layer and subependymal cells of the 
lateral ventricles (Lecca et al., 2008; Ceruti et al., 2009). GPR17 begins to be expressed once cells 
exit mitosis and undergo cell differentiation, and its expression continues and arises until 
differentiating cells reach premyelinating stages. After that GPR17 is down-regulated, thus no 
expression was found in mature, myelinating OLs (Boda et al., 2011). Consistent with this kinetics, 
early after birth GPR17 mainly decorates immature precursor cells (PDGFRα+, NG2+, MBP-) while 
during the first postnatal weeks GPR17 expression increases and is found in differentiating OLs. Its 
expression reaches a peak around postnatal day P24 in cells co-expressing markers of 
premyelinating stages such as PLP/DM20 and CD9, but then progressively diminishes in 
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concomitance with myelin production (Boda et al., 2011). Despite this pattern, GPR17-expressing 
OPCs are still present in the adult brain, distributed in both the white and grey matter and they have 
been extensively described to increase in number in response to brain injuries (Lecca et al., 2008; 
Ceruti et al., 2009; Boda et al., 2011 and 2015; Viganò et al., 2015). 
 
From a pharmacological point of view GPR17 is endogenously stimulated by extracellular 
uracil- and sugar-nucleotides (UTP, UDP, UDP-glucose and UDP-galactose) and by cysteinyl-
leukotrienes (LTC4 and LTD4). Extracellular nucleotides are associated to many different processes: 
from regulation of homeostasis to embryogenesis; while cysteinyl-leukotrienes are well-established 
inflammatory mediators (Ciana et al., 2006). A number of studies were conducted to determine the 
intracellular signaling pathways associated to GPR17 activation. Using pertussis toxin (PTX), 
which is a well-known inhibitor of Gαi-protein, and forskolin activator of adenylyl cyclase, 
Abbracchio and colleagues demonstrated that GPR17 is coupled by a Gαi-protein. Consequently, 
when activated GPR17 leads to inhibition of adenylyl cyclase and increases intracellular calcium 
concentration (Ciana et al., 2006). More recent studies used a small molecule proposed to be a 
selective agonist of GPR17: MDL29,951. These studies reported that GPR17 can engage the entire 
repertoire of GPCR intracellular adaptor proteins including G proteins of subfamilies Gαi, Gαs and 
Gαq and also β-arrestins. It follows that GPR17 stimulation perturbs cyclic adenosine 
monophosphate (cAMP) levels, as well as inositol phosphate and intracellular calcium 
concentrations, and also the ERK1/2 signaling pathway (Hennen et al., 2013). The activation of 
ERK kinase signaling was also shown by an independent study that described activation of 
alternative transduction pathways in response to the two classes of agonists. When stimulated by 
CysLTs GPR17 conformational change leads to recruitment of G protein-coupled receptor kinase 2 
(GRK2) isoform and a transient binding by β-arrestin. This determines a rapid phosphorylation of 
ERK kinase via a G protein-dependent mechanism and a sustained re-localization of cAMP 
response element-binding protein (CREB) into the nucleus. On the other side, upon purinergic 
ligands stimulation GPR17 recruits GRK5 isoform and forms a stable complex with β-arrestin. 
ERK kinase activation is slower and sustained while CREB is less activated (Daniele et al., 2014). 
However, CREB activation downstream of GPR17 stimulation is still controversial. MDL29,951-
mediated GPR17 activation reduces the activity of the cAMP/PKA/CREB cascade and also of 
exchange protein directly activated by cAMP (EPAC) (Simon et al., 2015). In addition Chen and 
colleagues showed that GPR17 overexpression has no effects on CREB re-localization (Chen et al., 
2009). On the contrary, they demonstrated that GPR17 overexpression correlates with increased 
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translocation of Id2 and Id4 to nucleus where they strongly inhibit OL maturation (Chen et al., 
2009). 
 
Due to its phylogenetic relationship with both P2Y and CysLT receptors and to the 
observation that extracellular nucleotides and CysLT levels are increased in injured areas, GPR17 
was firstly associated to the response to CNS injury (Lecca et al., 2008). It was described that early 
after the onset of an ischemic episode (from 24 to 48 hours after ischemia onset), neurons that 
surround the damaged area increase the expression of GPR17 in concomitance with heat shock 
protein 70 expression. However, at later stages (48 to 72 hours after ischemia) the number of 
GPR17-positive neurons was drastically diminished, most probably due to cell death since 
pharmacological and biotechnological inhibition of GPR17 correlated with an attenuation of cell 
death. At this time point on the other side, GPR17 was expressed by microglial-macrophagic cells 
that infiltrate the injured area, while 72 hours after ischemia onset GPR17 decorated proliferating 
OPCs, recruited to repair damaged parenchyma. Based on these observations it was proposed a dual 
role for GPR17, firstly as a “sensor of damage”, while at later stages as a director of the response to 
brain damage by being sequentially expressed in different cell types (Lecca et al., 2008). 
 
GPR17 is mainly studied for its role in OL differentiation. Many efforts have been made to 
clarify the role of GPR17 during the process, and some aspects are still controversial. It was firstly 
suggested that GPR17 may be an important promoter of the early stages of differentiation due to the 
observations that primary OLs or co-cultures of primary cortical neurons and OLs treated with 
UDP-glucose (UDP-Gluc) and LTD4 expressed increased levels of MBP myelin protein (Fumagalli 
et al., 2011; Daniele et al., 2014). In addition, in vitro studies showed that GPR17 knock-down 
arrests OPC differentiation at early stages (Fumagalli et al., 2011). On the other hand, in vivo 
studies of GPR17 functioning described that receptor knockout in mice determines precocious 
myelination onset. Furthermore, GPR17 forced overexpression leads to impaired OL differentiation 
and myelin defects, suggesting an inhibitory role for GPR17 during OL differentiation (Chen et al., 
2009). This conclusion was also supported by in vitro studies showing that GPR17 activation using 
MDL29,951 inhibits OL differentiation. Hennen and colleagues also proposed GPR17 inhibition as 
a strategy to promote myelination repair in MS (Hennen et al., 2013). 
 
Altogether these studies indicate that GPR17 may have a positive function in the early phase 
of OL differentiation but a negative role on final OL maturation, suggesting that GPR17 down-
regulation is needed to allow axonal myelination. Thus, the mechanisms underlying receptor 
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synthesis and stability may pay an important role in controlling OPC/OL-differentiation stages and 
myelination. 
 
To get more insights in the mechanisms that control GPR17 functioning, our research has 
focused on mechanisms underlying receptor intracellular trafficking. Intracellular trafficking 
impacts on many aspects of receptor expression/stability and signaling: i) it determines receptor 
levels at the plasma membrane, thus its availability to agonist/antagonist stimulation; ii) it regulates 
the total amount of receptor levels of expression, mainly by controlling receptor degradation and 
turnover rates; iii) it controls the temporal and spatial desensitization and resensitization upon drug 
administration. In recent studies we have characterized the endocytic transport of GPR17 and 
demonstrated that it undergoes both constitutive and agonists (LTD4 and UDP-Gluc) induced 
endocytosis. GPR17 endocytosis occurs via clathrin-coated vesicles. After internalization receptors 
are collected into Transferrin receptor (TfR)/early endosome antigen 1 (EEA1)-positive early 
endosomes (EE), a well-known station of sorting into different intracellular routes. From EE a 
portion of internalized receptors is sorted to lysosome for degradation, while a minor amount is 
recycled back to the plasma membrane. We also showed that GPR17 recycling mainly occurs 
through the so-called “short loop” pathway (see the following section) as indicated by the co-
localization with Rab4-positive vesicles (Fratangeli et al., 2013). In the light of these observations 
we extended our research on the molecular mechanisms underlying GPR17 endocytic sorting, by 
focusing our attention on the role of the class I post-synaptic density protein 95 - Drosophila disc 
large tumor suppressor protein - zonula occludens protein 1 (PDZ) binding motif expressed at 
GPR17 C-terminal. PDZ-binding motifs are a class of short sequence-specific domains largely 




The endosomal network 
As many other receptors and membrane integral proteins, GPR17, once internalized, 
undergoes trafficking into the endosomal network where is sorted between lysosomal degradation 
or plasma membrane recycling. 
 
Endosomes are an ensemble of tubular and vesicular structures distributed in the cellular 
cytoplasm and associated to many cellular processes. Molecules, lipids and solutes that are 
internalized by cells traffic through the endosomal pathways. Moreover, endosomal sorting 
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regulates receptor expression at the cell surface, receptor turnover, as well as receptor 
desensitization and resensitization after agonist stimuli (Hanyaloglu and von Zastrow; 2008). 
Endosomes constitute a spatial restricted compartment with peculiar biochemical/biophysical 
properties that allows the correct activity of many different enzymes, thus the processing of peculiar 
enzymatic reactions (Scott et al., 2014). Related to this, is also the new emerging view of 
endosomal compartments as important hubs for receptor signaling (Irannejad et al., 2015). The 
above reported are only a small part of the numerous functions that endosomes are beginning to be 
associated with and give an idea of why the regulation of endosomal network is emerging as an 
important topic in the regulation of cellular functioning in physiological and pathological 
conditions. Although endosomes are associated with many processes, I will describe their 
organization and regulation focusing on their role in the control of receptor transport and signaling. 
In doing this, I will use the word “cargo” to refer to the union of receptor and its ligand or the 
receptor alone without discriminate between the two, except when it is specifically required. 
 
Most of the studies that were conducted to characterize receptor traffic into the endocytic 
compartments relied on the use of transferrin (Tf) and TfR for tracking the recycling routes, while 
the EGF and EGF receptor (EGFR) were used to study the degradative pathway (Houtari and 
Helenius, 2011). On the base of these studies the “classic” view of endocytic transport assumes that 
cargo molecules reach endosomes after being internalized at the cell surface. Although it was 
demonstrated that this is not always true (refer to the following section), I will start to present cargo 
distribution in endosomal pathways considering that they enter endocytic compartments by 
endocytosis. 
Many different mechanisms mediate the initial step (internalization) of receptor endocytosis. 
They are generally divided in clathrin-dependent endocytosis (CDE), caveolae-dependent 
endocytosis (CavDE) and clathrin-independent endocytosis (CIE) mechanisms. Whether the 
endocytic pathway of cargo internalization also impacts on the endocytic sorting is still object of 
discussion (Grant and Donaldson, 2009). 
After internalization cargo molecules generally reach a tubulovesicular compartment called 
early endosomes (EE). Due to their peculiar biochemical/biophysical characteristics EE determine 
the release of receptor-ligand complex. Moreover EE are the first station of sorting into different 
pathways (Bissig and Gruenberg, 2013). EE are “classically” seen as the epicenter of all endosomal 
pathways and the progenitors of the other sub-compartments (Gruenberg, 2001). They are 
characterized by a mild-acidic pH concentration (pH 6.2 – 6.5) and their membranes are enriched in 
cholesterol and phosphatydilinositol 3-monophosphate (PI3P). Examples of EE-anchored proteins 
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are EEA1, Rab5 GTPase and PI3-kinase VPS34. It has been reported that in some cases cargo 
receptors that arrive at EE do not release their ligands and continue to signal for a prolonged period. 
Despite this observation, EE are never the ultimate destination of endocytic cargos. On the contrary, 
cargo molecules are generally sorted between two opposite destinies: degradation which occurs via 
late endosomes (LE)/lysosome pathway, or recycling which occurs by a number of different routes 
(Intro.Fig. 2) (Hanyaloglu and von Zastrow, 2008). 
 
 
Intro. Figure 2. Schematic representation of the “classic” endocytic pathways. 
After endocytosis EGFR, β2AR, CI-MPR and WLS are sorted into different endosomal pathways. 
EGFR and its ligand (EGF) are internalized into ILV and sorted to LE/lysosome for degradation. 
On the contrary, β2AR is recycled to the plasma membrane via the short-loop recycling pathway. 
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β2AR sorting in the recycling pathway depends on the SNX27-retromer-WASH macromolecular 
complex. WLS and CI-MPR are examples of cargos that are transported to the Golgi apparatus via 
retrograde transport. However, the two cargo molecules traffic through different pathways: while 
CI-MPR transport depends on the SNX-BAR retromer complex, the transport of WLS to the Golgi 
is regulated by the SNX3 retromer complex. Figure is adapted from Gallon and Cullen, 2015. 
 
 
Cargo receptors that are transported to LE are internalized into intra-lumenal vesicles (ILV) 
generated by a process of invagination of the EE membrane. It is not clear whether these ILV may 
reach LE also by free transport. However, a number of data established the formation of a 
multivesicular structure called multivesicular bodies (MVB), which is then transported to LE. 
Meanwhile MVB undergo a series of modifications that are collectively called “EE maturation” and 
contribute to determine the biochemical properties of LE (Houtari and Helenius, 2011). The most 
characteristic modifications are i) pH acidification (LE pH is around 5.0–5.5), determined by the 
activity of vacuolar-type protonic pump H+-ATPase; ii) Rab-associated protein switch from isoform 
5 to isoform 7; iii) phosphatydilinositol conversion from PI3P to PI(3,5)P2, although PI3P is still 
found in ILV (Bissig and Gruenberg, 2013). Cargo receptors that enter LE are generally (but not 
always) committed to lysosome for degradation (Houtari and Helenius, 2011). 
 
Notably, whereas the vacuolar part of EE undergoes membrane invagination and forms ILV 
committed to degradative pathway, the EE tubular structures are associated to cargo recycling 
(Gruenberg, 2001). Recycling may occur via different pathways that are tightly correlated with the 
biological functions of the cargo molecules. A basic distinction is between constitutive recycling 
and regulated recycling. Constitutive recycling is associated with molecules that are involved in the 
intake of substrates required for cellular metabolism such as cholesterol and its receptor (LDL 
receptor). These receptors of metabolites are supposed to be continuously in service to supply cells 
with essential metabolites, thus they do not require a regulated recycling (Grant and Donaldson, 
2009). Little information is available about constitutive recycling except that occurs via a bulk 
membrane flow. Some studies suggested that this pathway might exploit the Rab4-dependent 
regulated recycling pathway (Pfeffer, 2013). On the contrary, signaling receptors, for which the 
balance and the timing of cell surface re-exposure may impact on cell functioning, undergo a 
process of regulated recycling (Hanyaloglu and von Zastrow, 2008; Grant and Donaldson, 2009). 
This process is better characterized than the constitutive one and involves the sorting of different 
cargos into distinct intracellular pathways. The fastest regulated recycling pathway occurs by means 
of vesicles that bud from EE and directly reach the plasma membrane. This pathway is also called 
“short loop” recycling pathway and is regulated by the Rab GTPase isoform 4 (Rab4). A slower 
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way of recycling implies the traffic through tubule-vesicular compartments intermediate between 
EE and plasma membrane, which are called recycling endosomes (RE). This pathway is also 
referred to as “long loop” recycling and depends on the activity of Rab11 GTPase (Intro.Fig. 2). RE 
are generally (but not always) localized more proximal to the nucleus in respect to EE and have a 
less acidic pH than EE. However, it is important to remember that in some cell lines it is difficult to 
distinguish Rab4-positive vesicles, Rab11-associated RE and also EE as clearly separated 
compartments (Gruenberg, 2001). 
Finally, it is important to note that some cargos leave EE and are transported to the trans-
Golgi network (Intro.Fig. 2). Cargo return from EE to trans-Golgi is known as retrograde transport 
(Gallon and Cullen, 2015). The number of cargos described to traffic from endosomes to the Golgi 
complex is rapidly increasing. Probably the most characterized example of retrograde transport is 
the traffic of Wntless (WLS) that is required for Wnt transport to the plasma membrane, where is 
secreted. Thus, WLS recruits Wnt at the trans-Golgi, after that WLS/Wnt complex is transported to 
the plasma membrane (where the change of pH in the extracellular space determines Wnt release). 
WLS is then internalized in the EE and transported to the trans-Golgi via retrograde pathway. 
Similar mechanisms were also described for some other proteins and in particular for proteins 
involved in the transport of enzymes and proteins associated to endosomal compartments (EE, LE 
and lysosome) (Johannes and Popoff, 2008). 
 
The above described is the “classic” representation of endosomal organization. This view is 
rapidly evolving because of new evidences showing an extremely high interconnection between 
different endosomal pathways and between endosomes and many cellular processes. Endosomes 
receive material not only from the endocytic pathway, but also from the biosynthetic pathway 
(Golgi complex and also endoplasmic reticulum) and even the autophagic pathway (plasma 
membrane or autophagosomes). Endosomal transport is not anymore unidirectional: from EE to 
recycling, degradation or retrograde pathways. New evidences highlight a high interweaving 
between different compartments with cargos that although already internalized in LE are retrieved 
from degradation and re-directed to Golgi, RE, and extracellular secretion (exocytosis). Also RE 
were shown to receive cargos from biosynthetic pathway and re-direct them to EE and LE or 
plasma membrane (Johannes and Popoff, 2008; Houtari and Helenius, 2011; Scott et al., 2014). An 
important implication of this high grade of interconnectivity is that compartment 
biochemical/biophysical composition is extremely dynamic and constantly under remodeling. 
From compartments deputed at the regulation of intracellular trafficking, endosomes are 
now considered central elements in the regulation of many cellular processes: from 
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autophagocytosis, to regulation of focal adhesion and cell motility (Scott et al., 2014). Due to their 
peculiar biochemical and biophysical properties EE, LE and also lysosome are emerging as 
important hubs for the execution of specific enzymatic reactions. Related to this, is also the new 
concept of “signaling endosomes”, which considers endosomes master organizers of signaling 
pathways. Endocytic trafficking regulates the cell surface amount of receptors available for external 
signals and it is important to consider that receptors must reach endosomes (and a different pH) to 
rid of their ligands. Endocytic transport gives the opportunity for a fine, temporal and spatial 
regulation of receptor desensitization and resensitization. Moreover, endosomal sorting between 
degradation and recycling is a crucial crossroad determining signaling sustainment or down-
regulation. Endosomal membranes represent a microenvironment highly different from plasma 
membrane both in the lipid and protein composition. There are now increasing evidences of 
receptors whose signaling is activated upon endocytosis or that after internalization activate 
alternative signaling pathways. Finally, due to the spatial limitation of endosomal lumen, receptor 
activation in some cases may be more efficient when internalized in endosomal compartments 
(Scita and Di Fiore, 2010). 
 
Given the important role of endocytic trafficking in a number of cellular processes, it is not 
surprising that defects in the endosomal functioning are emerging to be associated to pathological 
conditions and development defects. Mutations in the molecular machineries that control endosomal 
sorting have been associated to neurological diseases such as Alzheimer and Parkinson diseases 
(Small and Petsko, 2015; Elkin et al., 2016; refer also to the following section). Furthermore, 
endosomal transport is exploited by different pathogens for their mechanisms of infection and 
reproduction (Salmonella, Coxiella burnetii, Legionella pneumophila, human papillomavirus, 
herpesvirus saimiri and also human immunodeficiency virus). Some toxins were also identified to 
target endosome sorting mechanisms. Examples are Shiga toxin produced by bacterium Shigella 
dysenteriae, and Cholera toxin produced by Vibrio cholera (Johannes and Popoff, 2008). 
 
Biochemical properties of endosomes 
What regulates such a highly complex network? The biochemical properties of different 
endosomal sub-compartments are fundamental for the correct functioning of endosome-associated 
processes (Scott et al., 2014). As previously reported, during maturation endosomes undergo a 
progressive acidification (Elkin et al., 2016). The peculiar pH concentration of endosomal 
compartments allows the release of ligands by internalized receptors and also the correct 
functioning of endosomal resident enzymes. This second consideration is also an important 
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regulatory mechanism that prevents the ectopic progression of enzymatic reactions outside their 
correct subcellular localization (Houtari and Helenius, 2011). 
Membrane lipid composition has a fundamental role in the regulation of endosomal network. 
Lipids present in distinct sub-compartments allow the organization of membrane micro-domains 
that are fundamental for the correct sorting of endosomal cargos (Bissig and Gruenberg, 2013). 
Furthermore, lipid composition determines the biophysical properties of different sub-
compartments, favoring the formation of vesicular and tubular structures. Membrane lipids attend at 
protein recruitment, and control the distribution and turnover rate of enzymes (Bissig and 
Gruenberg, 2013). Each endosomal compartment is characterized by a specific repertoire of 
phosphatydilinositoles (PIs), which has been proposed to constitute a specific phosphoinositide-
based code. Different PIs are univocally recognized by proteins that express specific domains as 
well as by unstructured protein regions where cluster of basic amino acids are present. Examples of 
PI-binding domains are the FYVE domain, the pleckstrin homology (PH) and the phox homology 
(PX) domains expressed by EE-associated proteins and recognizing PI3P-enriched membranes 
(Bissig and Gruenberg, 2013). Thus, the PI composition of each endosomal sub-compartment 
cooperates in recruiting the pattern of peculiar membrane-associated proteins that characterize each 
compartment. The repertoire of PIs is composed of seven molecules, which can be rapidly 
interchanged between each other by activity of different subtypes of PI kinases and PI 
phosphatases. The subcellular localization of these enzymes is tightly regulated. Thus, the 
regulation of PI composition by PI kinases and PI phosphatases constitutes an additional highly 
dynamic level of regulation. The functions in which PIs are implicated vary from regulation of 
signal transduction to the regulation of membrane-cytoskeleton interaction, membrane permeability 
and trafficking, among the others (Di Paolo and De Camilli, 2006). 
Each endosomal compartment also associates to specific members of the Rab family of 
small GTPases. As well as PIs Rab proteins exert essential functions for the maintaining of 
structural and functional endosomal compartment peculiarity by recruiting specific sets of proteins 
at the different endosomal membranes. As the other small GTPases Rab proteins switch between 
two different states: GTP association activates Rab GTPase, while its catalysis to GDP determines 
Rab inactivation. The activation state is controlled by Rab association to regulatory factors. In 
particular, guanine-nucleotide exchange factors (GEFs) promote GDP release and GTP binding, 
thus leading to Rab activation. On the contrary GTPase-activating proteins (GAPs) favor Rab-
dependent GTP hydrolysis and consequent Rab inactivation. This mechanism of control allows Rab 
protein spatial and temporal regulation, and consequential spatial and temporal regulation of Rab-
dependent processes (Elkin et al., 2016). 
	   26	  
SNARE (Snap receptor) proteins were associated to the regulation vesicles docking and 
fusion between different endosomal compartments by working in concert with Rab GTPases. 
SNARE proteins described to be involved in endocytic trafficking are syntaxins 13 and 6, VTI1a 
and VAMP5 (Gruenberg J., 2001). 
 
Molecular mechanisms underlying endosomal sorting 
Delivery to LE and lysosome 
Endosomal sorting between different pathways is a highly regulated process that requires the 
recruitment of complex macro-molecular machineries. The observation that impairment of either 
recycling or retrograde pathways results in a prominent increase of cargo delivery to lysosome 
leaded to the speculation that LE/lysosome is the dominant destiny of cargos that are retained 
longer in the EE (Gruenberg J., 2001; Hanyaloglu and von Zastrow, 2008). Cargo entering into the 
degradative pathway requires a process of ubiquitination that is the covalent binding of a 
polyubiquitin chain to a residue of lysine in receptor cytoplasmic domain. This reaction is catalyzed 
by a series of ubiquitin-activating enzymes (E1), ubiquitin-conjugating enzymes (E2) and ubiquitin 
ligases (E3). In particular for E3 ligases a large number of isoforms has been found, which are 
specific for different substrates. Ubiquitinated cargos are internalized into ILV and delivered to LE 
via MVB (Houtari and Helenius, 2011). Although alternative mechanisms have been described, 
sorting to LE/lysosome is commonly considered a process regulated by the Endosomal Sorting 
Complexes Required for Transport (ESCRTs) I, II and III that are required for the formation of ILV 
(Bissig and Gruenberg, 2013). The process is initiated by ESCRT 0 complex, which localizes at the 
EE due to the presence of a PI3P-binding FYVE domain in one of its subunit, named HRS. HRS 
also contains an ubiquitin-interacting motif that allows its interaction with ubiquitinated cargos. 
ESCRT 0 directly interacts with ESCRT I complex and is thought to load cargos to ESCRT I. 
ESCRT II and III are then responsibles of membrane invagination and cargo delivery in ILV. 
Another element thought to be important for ILV formation is sorting nexin 3 (SNX3) due to the 
observation that its knockout impairs ILV formation. However, the exact role of SNX3 in ILV 
formation is still unclear (Bissig and Gruenberg, 2013; Hanyaloglu and von Zastrow, 2008). 
In addition recent data have demonstrated that MVB-LE-lysosome fusions are regulated also 
by specific macro-molecular complexes: HOPS (late endosomal/lysosomal homotypic fusion and 
vacuole protein sorting) and COVERT (class C core vacuole/endosome tethering factor) (Houtari 
and Helenius, 2011; Scott et al., 2014). 
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Retromer complex-regulated recycling and retrograde transport 
The different structures of retromer complexes 
Cargo recycling, retrograde transport and retrieval from LE are all commonly regulated by 
macro-molecular machineries that share a core complex: the retromer. All these pathways have the 
plasma membrane as common final destination, although during their delivery cargo molecules may 
traffic through intermediate compartments. 
 
The retromer complex evolved with the primary role of regulating cargo retrograde 
transport. Accordingly, it was firstly identified in yeast to regulate endosome-to-Golgi retrieval of 
the CYP receptor (Vps10p). Despite this initial role, the retromer complex is an evolutionary 
conserved protein complex, which in mammals is described to regulate not only retrograde 
transport, but also recycling pathways. Furthermore, in mammals it seems that retromer has 
diversified into at least two distinct complexes. The “core” complex (common to all retromer 
complexes and also referred to as the retromer itself) is a heterotrimer composed by the association 
of vacuolar protein sorting 29 (VPS29), VPS35 and VPS26a or VPS26b. It is also known as the 
heterotrimeric sub-complex or the cargo-selective sub-complex. The core component of the 
complex is VPS35, to which VPS26 and VPS29 associate at the distal ends and in an independent 
way. It is generally accepted that the cargo-selective sub-complex works in concert with a 
heterodimeric sub-complex known as the membrane deformation sub-complex, or SNX-BAR sub-
complex. SNX-BAR sub-complex is constituted by any combination of SNX1 or SNX2 and SNX5 
or SNX6. When working in concert heterodimeric and heterotrimeric sub-complexes are 
collectively referred to as the SNX-BAR retromer complex. 
The observation that the cargo-selective sub-complex may regulate retrograde transport also 
independently by the SNX-BAR complex (e.g. by recruiting SNX3 protein) had leaded to the 
proposal that when interacting with SNX3 the retromer complex is called SNX3-retromer. This 
nomenclature was also suggested for other retromer complexes formed by the combination of the 
retromer “core” complex with different accessory proteins. An example is the complex formed by 
cargo-selective sub-complex/SNX-BAR sub-complex and SNX27 (Seaman, 2012). 
 
The sorting nexin family 
As reported above, sorting nexins (SNXs) are a large family of proteins characterized by the 
expression of a PX domain and involved in many endocytic functions. The PX domain mediates 
interaction with PI3P, thus, SNXs are cytoplasmic globular proteins that are enriched at EE 
membranes. SNX family can be divided into at least five groups: SNX-PX, SNX-BAR, SNX-
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FERM, SNX-PXA-RGS-PSX and SNX-MIT. The last two groups are very few characterized. As 
already mentioned, i) SNX1, SNX2, SNX5 and SNX6 (members of the SNX-BAR sub-complex), 
ii) SNX3 (member of the SNX-PX sub-family) and iii) SNX27 (member of the SNX-FERM sub-
family) have particular importance for retromer functioning. 
i) The members of the SNX-BAR sub-family are characterized by the expression of a 
Bin/Amphiphysin/Rvs (BAR) domain at the C-terminal. This domain is characterized by a concave 
surface in which are exposed positively-charged (basic) residues. Characteristics that make BAR 
domain particularly adapt to “sense” membrane curvature. Moreover, BAR domains allow the 
homo- and hetero-dimerization of SNX-BAR members (in particular of one SNX1/SNX2 with one 
SNX5/SNX6). A condition proposed to stabilize and even promote the formation of highly curved 
membrane tubular structures by forming higher helical complexes. These tubular structures have 
been described in EE micro-domains committed to recycling and in RE. 
ii) SNX3 is the most characterized member of the SNX-PX subfamily. SNX3 is important to 
mediate retromer recruitment at endosomal membrane by directly interacting with VPS35. In 
addition SNX3 was demonstrated to regulate WTL retrograde transport to the TGN independently 
from the SNX-BAR sub-complex (Intro.Fig. 3) (Carlton et al., 2005). 
iii) Three proteins belong to the SNX-FERM sub-family. They are SNX27, SNX17 and 
SNX31. These proteins are characterized by the expression of a FERM-like domain at their C-
terminal. SNX27 is unique among all SNXs because in addition to the FERM-like domain it also 
expresses a PDZ-domain. Thus, it has been shown to interact with a large number of different 
receptors and ion channels that express a PDZ-binding motif and to regulate their sorting into the 
recycling pathway. SNX17 has also been shown to regulate protein recycling. In particular it 
associates transmembrane proteins that express a NPXY motif in their cytoplasmic domain, by 
direct binding via its FERM-like domain. An established SNX17 cargo is the α5β1-integrin. 
Whether SNX17-mediated recycling depends on the association with the retromer complex and if it 
travels through the Rab11-dependent recycling is still unclear (Pfeffer, 2013). 
 
The functions of retromer complexes 
The retromer complex is considered the master regulator of sorting of many different cargos. 
More than hundred different receptors, transporters and ion channels were demonstrated to require 
retromer complex for their recycling (Steinberg et al., 2013). In addition, retromer-dependent 
retrograde transport has been demonstrated for cargos such as the cationic-independent mannose-6-
phosphate receptor (CI-MPR), sortilin receptor (SorLA) and WLS (Intro.Fig. 2). The current view 
of retromer complex functioning proposes that it serves as a general hub to which associate a 
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number of different proteins deputed to different tasks, from selection of cargos to micro-domain 
localization and membrane deformation. Among these proteins essential roles have SNXs. 
Although other mechanisms are now known (i.e. SNX17-mediated recycling), cargo 
recycling is largely considered to depend on retromer association with SNX-BAR sub-complex and 
with SNX27 adaptor protein (refer to the following section) (Intro.Fig. 2 and 3). With regards to 
retrograde transport on the other side, different complexes were proposed for different cargos. 
SorLA transport was shown to be mediated by retromer association to the SNX-BAR sub-complex, 
while as already mentioned WLS retrograde transport depends on SNX3-retromer (Intro.Fig. 2 and 
3) (Bissig and Gruenberg, 2013). An interesting observation is that the interaction with Rab7 
GTPase determines retromer localization also in the LE. Accordingly, in LE retromer was proposed 
to continue to recover cargos from degradation and re-direct them to the trans-Golgi. This 
trafficking pathway, which is also a form of retrograde transport, was shown to be necessary for the 
recovery of cargos that from the de novo synthesis pathway (i.e. the Golgi) transport lysosomal 
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Intro. Figure 3. Schematic representation of retromer complexes that regulate short loop 
recycling and retrograde transport. 
Cargos (e.g. β2AR) committed to short-loop recycling are recruited by the retromer complex 
through SNX27, which functions as an adaptor protein for cargos that express a type I PDZ-binding 
motif. The WASH complex is also required for the process by promoting actin polymerization. 
Cargos committed to retrograde transport (e.g. CI-MPR) are directly bound by the cargo-selective 
retromer sub-complex that is recruited to EE membranes by the concomitant actions of SNX3 and 
Rab7. The SNX-BAR sub-complex and microtubules are then required for membrane deformation 
and tubules stabilization, respectively. Figure is adapted from Seaman, 2012. 
 
 
Molecular mechanisms underlying protein sorting in the endosomal pathways 
The mechanistic details of retromer sorting into recycling/retrograde pathways are now 
starting to be characterized. The mechanism requires the following elements: i) Rab GTPases; ii) 
scaffolding and tubulation machineries; iii) motor proteins for vesicular transport; iv) a cargo 
selective machinery. 
i) Rab proteins are fundamental for many aspects of recycling pathway. Rab7 mediates 
retromer recruitment at endosomal membranes by acting in concert with SNX3 (Intro.Fig. 3), while 
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Rab4 and Rab11 are crucial regulators of the recruitment of complexes required for tubules 
stabilization, vesicles fission and fusion over the “short” and “long loop” pathways, respectively. 
ii) A number of studies have unveiled the mechanistic details of recycling tubules formation. 
As previously reported SNX-BAR due to the peculiar characteristics of the BAR domain and to the 
possibility of forming helical complexes has an important role in stabilizing and, probably, also 
promoting the curvature of tubular membranes. In detail, it was proposed that amphipathic helices 
expressed at the amino-terminal of SNX1 and SNX2 BAR domains, when anchored to the 
membrane, generate surface tension between membrane leaflets. To accommodate this tension the 
membrane is warped generating a positive curvature, which is immediately stabilized by the 
curvature-sensing properties of BAR domains. Despite this model of SNX-BAR-mediated 
membrane deformation, WLS and SNX3-retromer-associated retrograde transport was shown to do 
not depend neither on SNX-BAR complex nor on tubular structures. On the contrary, the process 
occurs via transport of vesicles that are generated by clathrin coating (Intro.Fig. 3) (Cullen and 
Korswagen, 2011). Another element shown to be required for tubular structures stabilization and 
vesicles fission is the Eps15-homology domain (EHD) family of proteins (EHD1-4). However, the 
molecular bases of EHD proteins functioning as well as of their interaction with the retromer 
complex are still undefined (Seaman, 2012). 
iii) Strictly required for endosomal sorting are microtubules and actin cytoskeleton. 
Microtubules have been joined to the regulation of vesicle transport. Notably, SNX5 and 6 associate 
retromer complex to the dynein-dynactin minus-end-directed motor complex by binding of its 
component p150glued. Far better characterized is the association of retromer-regulated sorting with 
actin cytoskeleton polymerization. Actin polymerization, at the endosomes, is regulated by the 
WASH (Wiskott-Aldrich syndrome protein and SCAR homolog) complex that acts as a nucleation-
promoting factor. The WASH complex is composed of five elements, which are WASH1, 
strumpellin, SWIP (strumpellin and WASH1 interacting protein), CCDC53 (coiled-coil domain-
containing protein 53) and FAM21 (family with sequence similarity 21). FAM21 is WASH 
complex subunit responsible of interaction with the retromer by direct binding of VPS35 subunit. 
WASH1 was also reported to interact with VPS35, but with less affinity than FAM21 (Seaman, 
2012). Moreover, FAM21 associates with CAPZα/β heterodimer that is a known actin capping 
protein. Thus, FAM21 mediates the release of actin capping leading to an extensive polymerization 
in the proximity of retromer complex–decorated membrane micro-domains (Intro.Fig. 3). The role 
of actin polymerization is now beginning to be understood. The process is supposed to be important 
for many reasons: i) it may contribute to form membrane micro-domains; ii) it may generate forces 
required for the elongation of membrane tubules and final vesicle fission; iii) it may be exploited by 
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motor proteins (i.e. myosin VI) that contribute to vesicle transport; iv) it may contribute to the 
maintaining of endosomal architecture; v) it favors the scission of vesicles from endosomal tubules 
by association with dynamin-2. Accordingly, loss of WASH complex components results in 
increased endosomal tubulation (Seaman, 2012). 
iv) How does retromer complex recognize cargos? Different mechanisms have been 
proposed. A first possibility involves the heterotrimeric cargo-selective sub-complex direct binding 
(and selection) of cargos. An example is CI-MPR and SorLA retrograde transport, which was 
demonstrated to depend on a direct interaction with VPS26. Notably, VPS26 in mammals is present 
in two isoforms (VPS26a and VPS26b), suggesting that different cargos may be recognized by 
different isoforms (Seaman, 2012). Also VPS35 is supposed to mediate the binding and sorting of 
some retromer cargos (Cullen and Korswagen, 2011). However a fundamental way for retromer to 
recruit cargos is by the use of adaptor proteins. Among these proteins a relevant role has SNX27 
(Steinberg et al., 2013). 
 
Short loop and long loop recycling pathways are supposed to share a similar mechanism and 
common machineries for cargo sorting at the level of EE. What are the factors that discriminate 
between the two pathways is beginning to be understood. SNX27 is now considered the main 
retromer adaptor protein for the recruitment of cargos that recycle via the Rab4-dependent pathway. 
The mechanism of SNX27 functioning will be detailed in the following part of this introduction. 
With regards to Rab11-dependent recycling, whether cargo sorting depends on SNX17, on a direct 
binding of cargo-selection sub-complex or is mediated by different adaptor proteins is still unclear. 
A putative candidate is SNX4, which was shown to decorate tubular-vesicular elements that from 
EE extend to the recycling compartments. SNX4 was also proposed to act in concert with dynein 
motor protein to regulate the entrance of TfR in the RE (Grant and Donaldson, 2009). Once 
transported to juxtanucluear RE cargos require to traffic to the plasma membrane. It was shown that 
tubular structures extending from RE towards the plasma membrane are also involved in the 
process. These tubules align along microtubules, and it was demonstrated that both microtubules 
and actin polymerization are required for their formation. An important factor shown to regulate 
RE-plasma membrane transport is ARF6. ARF6 activates both phospholipase D (PLD) and PI4P-
kinase (PI4PK) to remodel membrane lipid composition. PI4PK in particular catalyzes the 
formation of PI(4,5)P2 from PI4P, leading to recruitment of peculiar protein complexes required for 
tubule stabilization and elongation, and also for vesicle fission and fusion. A fundamental role in 
the recruitment of these complexes has also Rab11, which is specifically expressed into RE. In 
accordance RNA-interfering down-regulation of Rab11 or of its effectors affect recycling and alter 
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RE subcellular localization. Finally EHD1 was shown to be required for the stabilization and 
vesicular fission of recycling carriers involved in RE-to-plasma membrane traffic (Grant and 
Donaldson, 2009). 
 
The disregulation of retromer complex is now starting to be associated with the pathogenesis 
of different diseases. The knockout of retromer components VPS26a and VPS35 is lethal in 
mammals. Retromer deficiency has also been associated to the pathogenesis of neurodegenerative 
diseases like Alzheimer and Parkinson diseases (Seaman, 2012), and spastic paraplegia (Blackstone 
et al., 2011). The retrograde transport of APP relies on SorLA that, as previously said, is a retromer 
cargo. Notably, the levels of retromer protein expression are reduced in brain areas shown to be 
more prone to Alzheimer pathogenesis. Mutations in some components of the retromer machinery 
(i.e. SNX1, SNX3 and WASH) have also been associated to Alzheimer’s disease. Furthermore, a 
mutation of VPS35 that disrupts interaction with the WASH complex was associated with 
Parkinson’s disease. Accordingly, transgenic rats carrying this mutation show a degeneration of 
dopaminergic neurons (Small and Petsko, 2015). 
 
SNX27, an adaptor protein for receptor sorting into the short loop 
recycling 
SNX27 belongs to the SNX-FERM sub-family of SNX proteins. There are two different 
isoforms of SNX27 named SNX27 a and b. They distinguish only for the terminal carboxyl tail 
since SNX27b is 13 amino acids shorter than SNX27a (Rincon et al., 2007). Both the two proteins 
are broadly expressed in human and murine tissues and are considered constitutively expressed 
proteins, although their expression was directly demonstrated only for brain, hematopoietic cells, 
lung, spleen, testis, liver, pancreas and kidney (Rincon et al., 2007; Cai et al., 2011). 
 
As the other SNX members, SNX27 is characterized by the expression of a PX domain that 
is responsible for its recruitment to EE membranes. Furthermore, as well as SNX17 and SNX31, 
SNX27 also expresses a FERM-like domain at the C-terminal. However SNX27 is unique among 
SNXs, since it is the only member of the family that expresses a PDZ domain, which is localized at 
the N-terminal region (Rincon et al., 2007). 
 
Before explaining the roles and characteristics of SNX27, it is important to give some 
information regarding PDZ domains and PDZ domain-containing proteins. PDZ domains are 
protein-protein recognition modules that mediate interactions of PDZ domain-containing proteins 
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(also referred to as only PDZ proteins) with short sequence-specific domains, named PDZ-binding 
motifs, and between each other (Romero et al., 2011; Lau and Hell, 2001). They have obtained 
great interest on the basis of the observation that PDZ domain-containing proteins are implicated in 
the regulation of receptor signaling, subcellular localization and trafficking. PDZ-binding motifs are 
classified into three main classes on the basis of the biochemical properties of the amino acids that 
constitute their consensus sequence. PDZ domains are classified into three classes too, on the basis 
of the class of PDZ-binding motifs they interact with. The consensus sequence of PDZ-binding 
motif is essentially constituted by four amino acids. The most C-terminal amino acid is generally 
indicated as the P0 (position 0). The other ones are sequentially indicated as P-1, P-2 and P-3 starting 
from P0 residue. Class I PDZ-binding motif consensus sequence is –X-[S/T]-X-Φ (Romero et al., 
2011). The consensus sequences of type II and III PDZ-binding motifs are –X-Φ-X-Φ and –X-
[D/E/K/R]-X-Φ, respectively. Different type I PDZ domains may prefer specific amino acids in the 
different positions of PDZ-binding motif (e.g. Na+/H+ exchanger regulatory factor 1, NHERF1, 
prefers a leucine at position P0 and an aspartate or a glutamate at position P-2; Harris and Lim, 2001; 
Donowitz et al., 2005). However, residues up to position P-7 in the PDZ-binding motif –containing 
proteins have been shown to regulate interaction with PDZ domains. Furthermore, phosphorylation 
of either the PDZ-binding motif or the PDZ domain has been demonstrated to modulate the 
interaction (Harris and Lim, 2001; Donowitz et al., 2005). 
The structure of PDZ domains and the mechanistic details of PDZ domain – PDZ-binding 
motif interaction have been studied in details. PDZ-binding motifs are generally located at the C-
terminal end of protein chain, but in some cases have been described also internal PDZ-binding 
motifs. Interestingly, these internal motifs form a tridimensional structure that resembles that of a 
C-terminal tail. PDZ domains are compact, highly modular globular structures composed by six β-
strands and two α-helices. PDZ-binding motifs interaction occurs by means of a mechanism called 
“strand addition”. This mechanism implies PDZ-binding motif positioning in an extended groove 
which is located between a β-strand and an α-helix, and is called “peptide-binding groove”. A loop 
named “carboxylate-binding loop” is responsible for the correct positioning of PDZ-binding motifs 
(Harris and Lim, 2001). A hydrophobic niche is present in all the three types of PDZ domains and 
coordinates the P0 hydrophobic residue. On the other side, at the distal end of the second α-helix of 
the domain, different residues in the three types of PDZ domains are responsible for discrimination 
of different types of PDZ-binding motifs. In the type I PDZ domain of NHERF1 for example has 
been shown to be expressed a histidine residue (His212) to coordinate the hydroxyl group of S/T 
residue P-2 of type I PDZ-binding motifs (Hanyaloglu and von Zastrow, 2008). On the contrary, a 
hydrophobic residue is expected in type II PDZ-binding groove to coordinate the hydrophobic 
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residue express at P-2 by type II PDZ-binding motifs. However, it has been demonstrated that amino 
acids adjacent to the peptide-binding groove also contribute to determine the specificity of PDZ 
domains for different PDZ-binding motif -expressing proteins (Sheng and Sala, 2001). 
PDZ domains are frequently found in multiple copies on the same polypeptide. Moreover 
there are now strong evidences of PDZ domain-containing protein hetero- and homo-dimerization 
due to PDZ domain - PDZ ligand and PDZ domain – PDZ domain interactions. The important 
implication of this is the possibility to generate multi-protein networks below the plasma membrane 
that may be key regulators of cellular membrane signaling and of the maintenance of cell polarity 
(Sheng and Sala, 2001). These evidences leaded to the concept of “receptosomes” as an important 
element in receptor signaling. Receptosomes are complexes of different molecules that are 
aggregated in close proximity because they all contribute to a unique cellular process as, for 
example, signal transduction. They may include receptors, associated G-proteins, ion channels, 
kinases, and also proteins of the cytoskeleton and adhesion molecules (Bockaert et al., 2004). PDZ 
proteins may serve as scaffolds to maintain all proteins required for a signaling pathway in a spatial-
restricted region, thus improving both the accuracy and the efficiency of the process. This is 
particularly important if we think at processes such as synaptic signaling. In addition to improve the 
activation of post-synaptic signaling pathways, post-synaptic density protein scaffold maintains 
receptors in the correct position so that neurotransmitters released in the synaptic space efficiently 
and rapidly activate their target receptors (Sheng and Sala, 2001). Receptosomes are only an 
example of the many processes PDZ proteins are involved in. PDZ domain-containing proteins have 
been largely studied for their roles in receptor endocytosis, intracellular sorting and trafficking. 
Furthermore, they regulate GPCR association to heterotrimeric G-proteins, β-arrestins and GTPase 
regulatory proteins. Finally, PDZ proteins modulate GPCR interaction to their intracellular effectors 
such as PLC and protein kinase A (PKA) (Romero et al., 2011). 
 
SNX27 has been shown to prefer type I PDZ-binding motifs that express a valine at P0 
position or another amino acid with a small steric hindrance. Moreover, a positively charged or 
uncharged residue at position P-5 in PDZ-binding motifs is preferred. However SNX27 has been 
shown to interact also with PDZ ligands that do not respect these criteria and even with type II 
PDZ-binding motifs (Gallon and Cullen, 2015). Recently a bioinformatic work described the 
presence of a specific acidic amino acid sequence upstream at the PDZ-binding motif that is 
required (although not essential) for a high-affinity engagement by human-SNX27 PDZ domain. 
Notably, it was also reported that receptors that lack this sequence express a consensus sequence for 
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cargo phosphorylation, a post-translational modification that serves as a potent signal to induce 
SNX27 engagement (Clairfeuille et al., 2016). 
 
SNX27 is a cytoplasmic protein anchored to EE membranes by means of its PX domain. At 
the endosomes SNX27 also interacts with VPS26 subunit of retromer complex via a direct atypical 
interaction between VPS26 and SNX27 PDZ domain in a site distinct from the PDZ ligand-binding 
grove. Moreover SNX27 by means of its FERM-like domain directly interacts with FAM21 subunit 
of the WASH complex and with SNX1 of the SNX-BAR sub-complex. The overall result is that 
SNX27, due to its peculiar characteristic of expressing a PDZ domain, interacts with cargos that 
express a type I PDZ-binding motif and constrains them into specific micro-domains where are also 
recruited the retromer complex, the SNX-BAR sub-complex and the WASH complex. In other 
words SNX27 recruits cargos in the short loop recycling pathway, functioning as an accessory 
protein of the retromer complex that adapts the machinery for the binding of specific proteins (i.e. 
proteins that express a type I PDZ-binding motif) (Intro.Fig. 3). Notably, it was shown that in the 
absence of FAM21 SNX27 cargos are redirected to the Golgi apparatus instead of the recycling 
pathway (Lee et al., 2016). A great number of receptors and ion channels have been shown to 
interact with and depend on SNX27 for their recycling, and SNX27 itself was proposed to be the 
major regulator of Rab4-dependent recycling at the level of EE (Steinberg et al., 2013). Among the 
cargos whose recycling was demonstrated to depend on SNX27 are G protein-gated inwardly 
rectifying potassium channel (Kir3) (Lunn et al., 2007), the glucose transporter GLUT1 (Steinberg 
et al., 2013), 5-hydroxytryptamine type 4 receptor (Rincon et al., 2007), diacylglycerol kinase ζ-
associated protein (Joubert et al., 2004), the β2-adrenergic receptor (β2AR) (Lauffer et al., 2010) 
and, importantly, the glutamate receptors AMPA and NMDA (Cai et al., 2011). 
Due to its broadly role in regulating such a high number of cargos, it is not surprising that 
SNX27-kockout is lethal in the first weeks after birth. In particular SNX27 KO mice have a 
generalized growth defect that involves many different organs, suggesting that SNX27 function is 
fundamental for many tissues development (Cai et al., 2011). 
 
SNX27 retromer and pathologies 
 SNX27 deficiency in heterozygous-KO mice results in cognitive impairment and a 
pathological condition that resembles that of DS. Notably, SNX27 involvement in DS pathogenesis 
was strengthened by observation of SNX27 reduced levels of expression in DS brains, a defect 
determined by an impaired regulatory mechanism of SNX27 expression. SNX27 gene transcription 
is under the control of CCAAT/enhancer binding protein β (C/EBPβ), whose levels of expression 
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are reduced in DS because are directly inhibited by hsa21-associated micro-RNA 155 (mir-155) 
overexpression. Thus, it was proposed that SNX27 deficiency may contribute to DS cognitive 
impairment by disregulating AMPA and NMDA receptors recycling and, consequently, their levels 
at hippocampal synapses (Wang et al., 2013). Furthermore, SNX27 impairment contributes to the 
early onset of Alzheimer’s disease that is observed in DS patients. SNX27 was shown to associate 
with presenilin-1, a member of the γ-secretase complex. SNX27 binding of presenilin-1 determines 
γ-secretase complex dissociation, with the final consequence of decreasing γ-secretase activity and 
amylod-β peptide (Aβ) production. In DS reduced levels of SNX27 lead to an increased protease 
activity of γ-secretase and increased Aβ production (Wang et al., 2014). 
In addition to DS, SNX27 was associated to the pathogenesis of other diseases. McMillan 
and colleagues showed that a mutation in VPS26a retromer subunit previously characterized to be 
associated to atypical Parkinson affects endosomal transport of many different cargos by altering 
the association of retromer and SNX27 (McMillan et al., 2016). Finally it is important to note that a 
mutation in SNX27 gene was recently reported in humans, in a family affected by infantile 
myoclonic epilepsy and brain degeneration that determines an impairment of psychomotor 
development (Damseh et al., 2015). 
 
GPR17 PDZ-binding motif is required for receptor accurate 
localization at the cell surface by mediating a putative interaction with 
SNX27 
The mechanisms controlling GPR17 levels of expression and at the cell surface are partially 
known and their characterization may allow a better understanding of OL differentiation, given the 
well-established function of GPR17 in the regulation of the process. Furthermore, it may provide 
cues to understand GPR17 disfunction (Chen et al., 2009; Fumagalli et al., 2011; Boda et al., 2011; 
Viganò et al., 2016). 
To gain more insights on the regulation of GPR17 expression and signaling, we have 
recently began to characterize the mechanisms underlying receptor endocytic transport. Our 
previous results showing GPR17 endocytic transport partially to recycling pathway and partially to 
lysosome (Fratangeli et al., 2013), brought us to focus our attention on the mechanisms that control 
GPR17 endosomal sorting. As was extensively described in previous sections, endosomal sorting is 
a crucial event that determines whether receptor would undergo recycling to the plasma membrane 
or degradation, two opposite destinies leading to signaling sustainment or down-regulation, 
respectively. 
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To shed light on these mechanisms we have focused our attention on the C-terminal PDZ-
binding motif of GPR17. PDZ-binding motifs, as previously described, have been extensively 
associated to the regulation of receptor signaling, localization and trafficking (Romero et al., 2011). 
GPR17 expresses a class I PDZ-binding motif, which sequence, from P-2 to P0 residues, is –S-E-L. 
This motif is conserved in human and mouse receptors (Ciana et al., 2006), suggesting it has a 
functional role for association to class I PDZ domain-containing proteins (Harris and Lim, 2001). 
To understand the role of GPR17 PDZ-binding motif we generated receptor variants expressing 
site-directed mutations in residues important for association with PDZ proteins. In particular we 
generated: i) a stop codon before the -S-E-L sequence that leads to a truncated GPR17 (GPR17-
stop); ii) a substitution of residues at P-2 and P-1 with two alanines (GPR17-AAL); iii) a substitution 
of the residue at P-2 with an alanine (GPR17-AEL); iv) the addition of an alanine at the extreme C-
terminal after the P0 leucine (GPR17-SELA). The second and the third mutations target the P-2 
residue that is essential for the correct positioning of PDZ-binding motifs in the peptide binding 
groove of PDZ domains (Harris and Lim, 2001). The fourth mutation was previously described to 
disrupt PDZ ligand – PDZ domain interaction by steric hindrance (Lunn et al., 2007; Lauffer et al., 
2010). The effects of these mutations on receptor trafficking were analyzed by transient transfection 
of mutant constructs in Oli-neu (an oligodendroglial murine cell line, see Materials and Methods; 
Intro.Fig. 4) and HEK293 (Intro.Fig. 5) cells, followed by immunolabeling with anti-GPR17 
antibodies. As shown in introduction figure 4, labeling of Oli-neu with anti-GPR17-C-terminal 
antibody (αGPR17-Ct) and anti-NG2 to decorate the plasma membrane, demonstrated that 
disruption of PDZ-binding motif results in the altered subcellular distribution of GPR17. Confocal 
images showed that GPR17 mutants were mainly detected in intracellular vesicles scattered in the 
cytosol (Intro.Fig. 4 for GPR17-SELA and data not shown), whereas wild type receptors co-
localized with NG2, a marker of OPC plasma membrane. 
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Intro. Figure 4. GPR17-WT and GPR17-SELA distribution in Oli-neu. 
A-B’’ Oli-neu transfected with GPR17-wt or -SELA were fixed and double-labeled for GPR17 and 
NG2 (plasma membrane protein of immature OLs). Merges are shown in A and B. Note that almost 
no GPR17-SELA is detected at the cell surface (compare arrows in A-A’’ and arrows in B-B’’). 
Scale bar: 10 µm. 
 
 
To gain more insights into the defects found in the trafficking of GPR17 mutants, we took 
advantage of an antibody raised against GPR17 N-terminal extracellular domain (αNt-GPR17; 
Table 1) to label, at 37°C, wild type and mutant receptors expressed at the cell surface of living 
HEK293 cells. After 30 minutes (min) cells were fixed and GPR17 receptors were identified by 
labeling with the appropriated secondary antibody. Confocal microscopy analysis of samples 
revealed that wild type GPR17 was still retained at the cell surface as shown by co-localization with 
cadherins (markers of plasma membrane, arrows in Intro.Fig. 5E a-a’’). Mutant GPR17 were also 
labeled with αNt-GPR17 antibody, suggesting that their synthesis and biosynthetic transport were 
not inhibited. However they were mainly detected into intracellular vesicles (Intro.Fig. 5A-E). 
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Double-immunostaining with anti-TfR antibody revealed that a number of these vesicles correspond 
to endosomes (Intro.Fig. 5E d-d’’). Altogether these results suggested that GPR17 PDZ-binding 
motif mutants were mainly retained in endocytic vesicles, indicating that PDZ-binding motif is 
specifically involved in the regulation of receptor endocytic trafficking. 
In the light of these data we looked for candidate proteins capable of interacting with the 
GPR17 PDZ-binding motif. Among PDZ domain-containing proteins known to regulate GPCR 
endosomal trafficking and/or signaling we selected SNX27 because: i) it interacts with type I PDZ-
binding motifs (Lunn et al., 2007; Rincon et al., 2007); ii) it is a well-established regulator of Rab4-
dependent recycling (Temkin et al., 2011; Steinberg et al., 2013), which is the pathway exploited by 
GPR17 (Fratangeli et al., 2013); iii) it has been shown to interact with a number of different 
receptors and ion channels and among them are also many GPCRs (Lauffer et al., 2010; Steinberg 
et al., 2013); and iv) its expression in the CNS is well established (Cai et al., 2011; Wang et al., 
2013). In addition we analyzed the role of NHERF1, a widely expressed scaffold protein that has 
been reported to affect the trafficking and signaling of the purinergic receptor P2Y12 (Nisar et al., 
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Intro. Figure 5. PDZ-binding motif mutated GPR17 receptors are retained intracellularly. 
A-D Representative immunofluorescence micrographs showing HEK293 cells transfected with 
GPR17-wt (A) or with plasmids coding for GPR17 PDZ-binding motif mutants (i.e. stop, B; AEL, 
C; or AAL, D). Live cells were incubated 30min at 37°C with the αNt-GPR17, fixed and stained 
with anti-rabbit IgG conjugated to Cy2. E Representative immunofluorescence micrographs 
showing HEK293 cells transfected with GPR17-wt (a-b’’) or GPR17-SELA (c-d’’). Live cells were 
incubated 30min at 37°C with the αNt-GPR17 and double-immunostained for cadherins (marker of 
plasma membrane, a-a’’ and c-c’’, arrows) or TfR (marker of endosomes, b-b’’ and d-d’’, arrows). 
Scale bars: 10 µm. 
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To test whether SNX27 and NHERF1 interact with GPR17 PDZ-binding motif we 
performed pulldown experiments using two different peptides covalently conjugated with 
Sepharose 4B resin beads: i) a peptide corresponding to the last 19 amino acids of GPR17 C-
terminal tail (referred to as CT peptide) and ii) a second peptide identical to CT, but lacking the 
PDZ-binding motif (referred to as ΔCT). Interestingly, neither CT nor ΔCT peptide could isolate 
NHERF1 from Oli-neu cell extracts, whereas CT peptide isolated at least 10 times more SNX27 
than ΔCT (Intro.Fig. 6), suggesting that SNX27 may interact with the C-terminal PDZ-binding 




Intro. Figure 6. GPR17 PDZ-binding motif interacts with SNX27 in vitro. 
Oli-neu cell lysates (500 µg of proteins) were incubated with CT or ΔCT peptides conjugated to 
sepharose beads (20 µL). Proteins eluted from the beads and aliquots of total lysates (30 µg of 
proteins, Lys) were analyzed by Western blotting with antibodies against NHERF1 or SNX27. A 
Immunoblots representative of three independent experiments are shown. B Ponceau S staining of 
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AIMS OF THE WORK 
Altogether our results indicate that GPR17 PDZ-binding motif plays an important role in the 
endocytic trafficking and cell surface expression of GPR17 via a possible interaction with SNX27. 
Based on these observations we decided to definitively demonstrate the specific role of SNX27 in 
the regulation of GPR17 endosomal sorting, with specific regards to sorting between degradation 
and recycling. Furthermore, we investigated whether SNX27 down-regulation occurring in 
pathological conditions (e.g. DS or SNX27 gene mutation; Wang et al., 2013; Damseh et al., 2015) 
may have implications for OL differentiation, with the aims to reveal further mechanisms 
underlying defects of myelination (see DS) and to identify new pharmacological strategies to target 
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MATERIALS AND METHODS 
Antibodies and reagents 
Primary antibodies used in this study are listed in Table 1. αNt-GPR17 and αGPR17-Ct 
antibodies were obtained by immunization of rabbits and affinity purification, and were 
characterized as previously described (Fratangeli et al., 2013). Anti-rabbit or anti-mouse IgG 
conjugated to horseradish peroxidase, anti-rabbit IgG-light chain conjugated to horseradish 
peroxidase, biotinylated anti-goat IgG, and reagents UDP-Gluc, dithiothreitol (DTT) and protease 
inhibitor cocktail were purchased from Sigma-Aldrich (Milan, Italy). AlexaFluor® 488-conjugated 
streptavidin, His-Pur-Ni-NTA resin and TurboFECT transfection reagent were from Thermo-Fisher 
Scientific (Waltham, MA, USA), while JetPei transfection reagent was purchased from Polyplus 
Transfection (Illkirch, France). The anti-rat IgG conjugated to horseradish peroxidase, AlexaFluor® 
488 -conjugated goat anti-mouse or anti-rabbit IgGs and streptavidin conjugated to AlexaFluor® 
555 were from Life Technologies (Monza, Italy). Goat anti-rabbit IgG and goat anti-mouse IgG 
conjugated to IR Dye 800 CW and IR Dye 680 RD, respectively, were from Li-Cor Biosciences 
(Cornaredo, Milan, Italy). We purchased the anti-mouse, anti-rabbit and anti-rat IgGs conjugated to 
Cy3-, Cy5-, Cy2-, DyLight488- or FITC-, from Jackson ImmunoResearch Laboratories (West 
Grove, PA, USA). 
 
Plasmids, oligonucleotides and site-directed mutagenesis 
pCMVEntry-human(h)SNX27 was purchased from OriGene Technologies (Rockville, MD 
20850). To remove Flag epitope SNX27 cDNA was sub-cloned in a pcDNA3.1 (SNX27 wild-type), 
while to conjugate hSNX27 with a poly-histidine epitope (his-SNX27) we sub-cloned SNX27 
cDNA into a pRSET B vector (Life Technologies). The cloning of GPR17 cDNA into 
pcDNA3.1/V5-His-TOPO was previously described (Lecca et al., 2008), while for Flag epitope 
conjugation, GPR17 was sub-cloned in a pFLAG-CMV2 expression vector (Life Technologies). 
We also purchased from Life Technologies the pcDNA3 vector backbone. The pMGP-155 vector 
for mir-155 expression and pMGP vector control were from Addgene (O’Connel et al., 2009). 
Short-hairpin (sh)-RNAs scrambled (CSHCTR001-CU6) and targeting SNX27 mRNA sequences 1) 
catgaggctgataacctag, 2) ggccattctcattatcaga, 3) ctggcacctaatgaatttc and 4) actctacgtccagaactat cloned 
into a psi-U6.1 expression vector, and carrying EGFP expression cassette, were purchased from 
GeneCopoeia (Rockville, MD). Mmu-miR-155-5p (5’-UUAAUGCUAAUUGUGAUAGGGGU-3’) 
and hsa-miR-155-5p (5’-UUAAUGCUAAUCGUGAUAGGGGU-3’) primer sets to analyze mir-
155 expression by quantitative real time PCR (qRT-PCR) were purchased from Exiqon (Vedbaek, 
Danmark). Site directed mutagenesis of GPR17 cDNA in pcDNA3.1/V5-His-TOPO and in pFLAG-
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CMV2 vectors and of the SNX27 cDNA cloned in pRSET B were done using the QuickChange 
Lighting Site-Directed Mutagenesis Kit (Agilent Technologies, La Jolla, CA, USA) accordingly to 
manufacturer’s instructions. Primers used for the mutagenesis are here listed: 
Stop For, 5’-CTCCCTGAGTGCCTGATCCGAGCTGTG-3’; 
Stop Rev, 5’-CACAGCTCGGATCAGGCACTCAGGGAG-3’; 
RAAL For, 5’-CCCTGAGTGCCCGAGCCGCGCTGTGAGAAGG-3’; 
RAAL Rev, 5’-CCTTCTCACAGCGCGGCTCGGGCACTCAGGG-3’; 
RAEL For, 5’-CCCTGAGTGCCCGAGCCGAGCTGTG-3’; 
RAEL Rev, 5’-CACAGCTCGGCTCGGGCACTCAGGG-3’; 
RSELA For, 5’-GTGCCCGATCCGAGCTGGCATAAGGGCAATTCTGCAGA-3’; 
RSELA Rev, 5’-TCTGCAGAATTGCCCTTATGCCAGCTCGGATCGGGCAC-3’; 
KSELA For, 5’-GCCAAGTCAGAGCTGGCATGATCTAGAGGATCCC-3’; 
KSELA Rev, 5’-GGGATCCTCTAGATCATGCCAGCTCTGACTTGGC-3’; 
KAEL For, 5’-GCTCGCTGAGTGCCAAGGCAGAGCTGTGATCTAGAGG-3’; 
KAEL Rev, 5’-CCTCTAGATCACAGCTCTGCCTTGGCACTCAGCGAGC-3’; 
SNX27 H114A For, 5’-GAATGTTGAGGGGGCGACAGCCAAGCAGGTGGTGGACC-3’; 
SNX27 H114A Rev, 5’-GGTCCACCACCTGCTTGGCTGTCGCCCCCTCAACATTC-3’. 
Constructs were sent to Eurofins MWG Operon (Ebersberg, Germany) for sequencing. 
 
Cell culture 
Oli-neu is a cell line derived from immortalized murine OPCs and was kindly provided by 
Professor J. Trotter of the University of Mainz (Germany). Oli-neu were maintained in Sato 
medium (13,4 g/L DMEM powder, 2 g/L NaHCO3, 10 µg/mL Transferrin, 10 µg/mL Insulin, 100 
µM Putrescine, 200 nM Progesterone, 500 nM TIT, 220 nM Na-selenium, 520 nM L-Thyroxin, 25 
µg/mL Gentamicin) containing 1% horse serum (HS) (from here on I will refer to Sato containing 
1% HS as only Sato medium) at 37°C and 10% CO2 (Jung et al.; 1995). To allow Oli-neu 
differentiation cells were cultured in conditioned medium (CM) composted of 1:1 Sato and neuron 
conditioned medium. Neuron conditioned medium was obtained from 12 and 14-div (days in vitro) 
old neuronal cortical cultures from 18-day old rat embryos and was kindly provided by Dr. M. 
Passafaro (CNR, Institute of Neuroscience). As described in Fratangeli et al., 2013 exposure to CM 
promotes Oli-neu exit from mitosis and differentiation, in a manner that resemble that of primary 
OPCs. Our analysis and quantification of different markers of OL differentiation demonstrated that 
after 48-hours (hr) of culture in differentiating conditions nearly 80% of cells of the whole cell 
culture express GPR17, while at 72hr after CM exposure the percentage of cells expressing GPR17 
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is reduced and we observed a concomitant expression of MBP (Meth.Fig. 1 and Fratangeli et al., 
2013). Thus we analyzed the expression of GPR17 in control (ctr) or plasmid transfected cells 72hr 
after transfection and 48hr after treatment with CM. HEK293 cells were maintained in DMEM 
medium containing 10% Fetal Bovine Serum (FBS), 1% Penicillin/Streptavidin (P/S) and 2 mM L-
glutamine (from here on I will refer to 10%FBS 1%P/S 2mM L-glutamine in DMEM as only 
DMEM medium), at 37°C and 10% CO2. Primary cultures of fibroblasts derived from DS embryos 
and euploid controls were a kind gift of Professor Lucio Nitsch (University of Napoli Federico II; 
Department of Molecular Medicine and Medical Biotechnology) and were maintained in DMEM 
medium further containing 10 ng/µL FGF, at 37°C and 10% CO2. Primary cultures enriched in 
OPCs were prepared following previously described methodologies (Fumagalli et al., 2011; 
Medina-Rodriguez et al., 2013). In brief, cortices of postnatal day 3 (P3) C57BL/6 mice or P2 
Sprague-Dawley rats were used to obtain mixed glial cultures which then underwent a process of 
selection based on selective detachment upon shaking on a rocking plate. OPCs were then 
transferred to Petri dishes or coverslips (previously treated with poly-L-lysine, Sigma-Aldrich, 
Milan) and expanded by maintaining in Sato medium without tyroxine and supplemented with 10 
ng/mL bFGF and 10 ng/mL PDGF-AA. Cell transfection was done two days later. After 




JetPei (PolyPlus) or TurboFECT (Thermo Scientific, Rockford, Illinois) were used as 
transfection reagents in accordance with manufacturer’s instructions. The appropriate amounts of 
cells were seeded onto 24x24 mm glass coverslips or 60 mm Petri dishes 24hr before the 
transfection. In particular we seeded 150,000 HEK293/coverslip, while Oli-neu cell number 
depended on the time span of the following differentiating treatments and ranged from 30,000 to 
75,000/coverslip and from 130,000 to 150,000/petri dish for 72hr and 48hr of differentiation 
respectively. 0.5 µg and 1 µg of DNA were used respectively for Oli-neu and HEK293 cells onto 
24x24 mm coverslips, while Oli-neu in 60 mm Petri dishes were transfected using 1 µg of DNA. 
For experiments of co-transfection, vectors were mixed in a 1:1 ratio. 24hr after transfection the 
medium was replaced with fresh medium or, in the case of Oli-neu, with CM to promote cell 
differentiation. HEK293 cells were fixed 48hr after transfection (see below), while Oli-neu cells 
were fixed or lysed as described below after 72hr or 96hr (48hr or 72hr of differentiation, 
respectively). 
 
	   47	  
 
Meth. Figure 1. Quantification of GPR17 and MBP expressing cells in 48hr-differentiated Oli-
neu. 
Oli-neu cells were cultured in either Sato medium or CM (neuron-conditioned medium) to induce 
cell differentiation. After 48hr cells were fixed and double-immunolabeled with αGPR17-Ct and 
anti-MBP antibodies. The numbers of GPR17 and of MBP –expressing cells were counted in 
twenty optical fields/coverslip and in a total of 6 coverslips for each group and results were then 
reported as a percentage of the total number of counted cells set to 100%. As indicated by 
histograms the percentage of GPR17-positive cells increases upon Oli-neu exposure to CM, and we 
also observed the appearance of MBP-expressing cells, suggesting that cells are under 
differentiation. The results are the means (±s.e.m.) of three independent experiments. 
 
 
Cell lysis and fractionation of nuclei/cytosol 
Different lysis buffers were used depending on the procedures used after extraction. For 
pulldown experiments we used buffer B (PBS, pH 7.4, 2.5 mM EDTA and 10% glycerol containing 
0.5% Nonidet P40 and protease inhibitors). When pulldown was performed using His-Pur-Ni-NTA 
resin EGTA was removed from the buffer. For other experiments we lysed cells using buffer A (150 
mM NaCl, 2 mM EGTA, 50 mM Tris-HCl, pH 7.5, containing 1% Triton X-100 and protease 
inhibitors). Cell extracts were harvested and incubated on ice for 30min, followed by 30min 
centrifugation at 12,000 rpm at 4°C. For nuclei/cytosol fractionation, buffer C (10 mM Hepes, 10 
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mM KCl, 1.5 mM MgCl2, 0.5 mM DTT, pH 7.9, containing protease inhibitors) was used to collect 
cells, while lysis was obtained mechanically using 2.5 mL syringes and 18Gx1.5’’ needles 
(Terumo, Leuven, Belgium). Nuclei were pelletted by centrifuging samples at 800xg for 10min at 
4°C and cytosolic fraction was collected. Buffer D (400 mM NaCl, 20 mM Hepes, 25% glycerol, 
0.2 mM EDTA) was then used to resuspend the nuclear fraction. Samples were incubated on ice for 
40min and finally centrifuged at 40,000 rpm and 4°C for 40min. To concentrate samples, when 
required, we precipitated proteins by means of 4-volumes of 100% acetone and overnight 
incubation at -20°C. The following day samples were centrifuged at 10,000 rpm 4°C for 30min and 
solubilized in Leammli’s sample buffer (3% SDS, 125 mM Tris-HCl pH 6.8, 6.6% glycerol, β-
mercaptoethanol and bromophenol blue). 
 
Protein purification from bacteria extracts 
For expression of his-SNX27 in bacteria we used BL21DE3 E. coli strain. We cultured 
bacteria until OD600 0.6-0.8 and then induced expression of his-SNX27 by administration of 0.1 
mM isopropyl β-D-1-thiogalactopyranoside (IPTG) to the culture followed by incubation for 3hr at 
37°C. Bacteria were pelletted and resuspended in 20 mM phosphate buffer. Cell lysis was obtained 
by freeze-thaw cycles between liquid nitrogen and water bath at 42°C. For protein purification from 
bacteria extracts, we used nickel-nitrilotriacetic acid resin (His-Pur-Ni-NTA; Thermo-Fisher 
Scientific, Waltham, MA, USA) according to the manufacturer’s instructions. 200 µL of resin were 
used to purify his-SNX27 derived from a 200 mL bacteria culture. Amicon® Ultra Centrifugal 
Filter (Millipore) were finally used to remove imidazole from the eluted samples. 
 
Protein pulldown 
For proteins pulldown we used a GPR17 C-terminal peptide (CT) or a GPR17 C-terminal 
peptide lacking the PDZ-binding motif (ΔCT) previously conjugated at a concentration of 2 
mg/mL-of-matrix with CNBr-activated sepharose 4B resin beads. 500µg of Oli-neu protein extracts, 
50µL of BL21DE3 bacteria extracts or 2µg of purified his-SNX27 were incubated overnight at 4°C 
with 20 (Oli-neu) or 10 (bacteria and purified his-SNX27) µL of the resins in buffer B containing 
0.2% Nonidet P40 and protease inhibitors. The following day samples were washed with buffer B 
containing 0.2% Nonidet P40 (three times) and with buffer B without detergent (three times). 
Finally, proteins bound to the resins were eluted in Laemmli’s sample buffer. When using His-Pur-
Ni-NTA resin EGTA was removed from the buffer B. 
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Western blotting 
Proteins were separated by SDS-PAGE using 8% or 12% acrylamide/bisacrylamide gels, 
and transferred onto 0.45 µm nitrocellulose membrane (Whatman, Dossel, Germany). 
Polyvinylidene Fluoride (PVDF) membranes (Amersham HybondTM-P; GE Healthcare) were 
required for GPR17 immunostaining. For Odyssey Li-Cor detection we used either 0.22 µm 
nitrocellulose membrane or PVDF (Immobilon-FL; Millipore). We blocked aspecific binding sites 
by overnight incubation at 4°C in Tris Buffered Saline (TBS) (25 mM Tris-HCl, pH 7.4 and 150 
mM NaCl) and 5% non-fat milk (blocking buffer). TBS containing 5% non-fat milk and 1% bovine 
serum albumin (BSA) was required for immunostaining using anti-SNX27 antibody. Primary and 
secondary antibodies were diluted in TBS containing 5% non-fat milk and 0.3% Tween 20, while 
0.1% Tween 20 was used for SNX27, ID2 and GAPDH, and 0.05% Tween 20 was required for 
MBP staining. 5% non-fat milk in TBS was utilized for anti-GRK2, anti-mTOR, and anti-phospho-
mTOR antibodies. Incubation was done for 2hr and 1hr for primary and secondary antibodies 
respectively, except for anti-MBP antibody which was incubated overnight at 4°C. Extensive 
washes were done between antibody incubations and after secondary antibody staining. Anti-rabbit 
or anti-mouse IgGs conjugated to horseradish peroxidase were diluted 1:50,000 with exceptions for 
SNX27 and ID2 immunostaining, for which dilution was 1:25,000, and horseradish peroxidase-
conjugated anti-rat IgG which was used at 1:5,000 dilution. Chemiluminescent detection was done 
using SuperSignal WestPlus ECL substrate (Thermo-Fisher Scientific, Waltham, MA USA) and 
Amersham Hyperfilm ECL (GE Healthcare, Little Chalfont, UK). For immunostaining detection 
using Odyssey Li-Cor 5% non-fat milk in Phosphate Saline Buffer (PBS; 137 mM NaCl, 3 mM 
KCl, 8 mM Na2HPO4x2H2O and 2 mM NaH2PO4xH2O) and PBS containing 5% non-fat milk and 
0.1% Tween 20 were used as blocking and washing buffer (and for antibody dilution), respectively. 
IR Dye 800 CW anti-rabbit and IR Dye 680 RD anti-mouse secondary IgGs were diluted 1:10,000. 
Their intensities were acquired using a Li-Cor Bioscience Odyssey CLx infrared imaging system 
(Li-Cor Bioscience, Cornaredo, Milan, Italy). 
If necessary, membranes were stripped to detach bound antibodies by washing with glycine 0.2 M 
buffer, pH 2.2. 
 
Immunolabeling of live cells and cell fixation 
We firstly washed cells with PBS containing 0.1 mM CaCl2, 1 mM MgCl and 1% HS 
(PBS++ 1% HS) for Oli-neu, 1% BSA for HEK293 cells (PBS++ 1% BSA), then, incubated them 
for 35min at 4°C with αNt-GPR17 or anti-FLAG epitope (αFLAG) antibodies diluted in PBS++ 1% 
HS or 1% BSA (refer to Table 1 for antibody dilutions). Antibody excess was removed by washing 
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with PBS++ 1% HS/BSA at 4°C and samples were incubated in complete Sato/DMEM medium 
containing 100µM UDP-Gluc at 37°C 10% CO2 to induce receptor internalization. Internalization 
was induced for 20min, after that endocytosis was blocked by taking samples to 4°C. When 
required we used 50 mM glycine buffer (pH 2.8) to detach antibody at cell surface, while we allow 
receptor distribution into endosomal pathways by re-incubating samples in complete Sato or 
DMEM medium without agonist at 37°C, 10% CO2. After PBS washing, samples were fixed with 
4% paraformaldehyde in phosphate buffer (pH 7.3) containing 4% sucrose (incubation for 10 and 




We permeabilized fixed cells for 5min (10 minutes for HEK293) with PBS containing 0.3% 
Triton X-100 (0.1% Triton X-100 was used for samples fixed after in vivo labeling). Cells were then 
incubated for 30min in 0.1 M glycine (pH 7.4) to neutralize aldehyde complexes. The following 
washes and antibody dilution were done using 10 mM PBS containing 450 mM NaCl and 0.2% 
gelatin (IF buffer). Incubations of primary and secondary antibodies conjugated to the appropriate 
fluorophores were done for 2hr and 45min at room temperature (RT), respectively. Primary 
antibody dilutions are summarized in Table 1, while secondary antibodies were diluted 1:200. We 
finally reduced saline concentration by washing with PBS and swiftly with distilled H2O, and 
mounted coverslips on slides using Mowiol 4-88 (Polyscience). For goat anti-SNX27 primary 
antibody detection we used a donkey anti-goat IgG conjugated with biotin (1:200 dilution, 45min 
incubation), which was then revealed using an AlexaFluor® 488 –conjugated streptavidin (1:200 
dilution, 45min incubation). Endogenous biotin and avidin were blocked using avidin/biotin 
blocking kit (Vector Laboratories, Burlingame, California). 
 
Mouse colony (in collaboration with the laboratory of Prof. Renata Bartesaghi of the University of 
Bologna) 
Ts65Dn female mice were purchased from Jackson Laboratories (Bar Harbour, ME, USA) 
and mated with C57BL/6JEi x C3SnHeSnJ (B6EiC3) F1 males to maintain the original genetic 
background (partial trisomy of chromosome 16; Reeves et al., 1995). Analysis of mice karyotypes 
was done by qRT-PCR, as reported in Liu et al., 2003. Postnatal day zero (P0) was used to refer to 
the date of birth, in accordance with common conventions. Animals health and comfort were always 
cared and were under the control of veterinary service. Animals underwent a 12:12 hr dark/light 
cycle and were always supplied with water and food ad libitum. Bologna University Bioethical 
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Committee oversaw that experiments were in accordance with Italian and European Community 
law for the use of experimental animals. All efforts were made to minimize both the number of 
animals required and animal suffering. 
 
Immunohistochemistry (in collaboration with the laboratory of Prof. Maria Pia Abbracchio and the 
group of Prof. Stefania Ceruti, Università degli Studi di Milano) 
Brain sections of euploid or Ts65Dn mice at 45 post-natal days were kindly provided by the 
laboratory of Prof. Renata Bartesaghi (University of Bologna) and were prepared as described in 
Guidi et al., 2014. Samples were provided as free-floating or paraffin-embedded sections and were 
processed for immunohistochemistry in accordance with the protocol described in Boda et al., 2011. 
PBS containing 5% normal goat serum and 0.3% Triton-X 100 was used for primary and secondary 
antibody incubations. Primary antibodies were incubated overnight at 4°C while secondary 
antibodies were incubated for 1hr at RT. Primary antibody dilutions are summarized in Table 1, 
while secondary antibodies, covalently conjugated with appropriate fluorophores, were diluted 
1:600. For GPR17 immunostaining was used the high-sensitivity Tyramide Signal Amplification kit 
(Perkin Elmer, Monza, Italy) in accordance with manufacturer’s instructions. Nucleus staining was 
done by means of Hoechst 33258 dye (Life Technologies) diluted 1:10,000 in PBS 1:1 methanol, 
samples were incubated for 20min at RT. Slides were mounted using Fluorescent Mounting 
Medium (Dako Italia, Milan, Italy). MBP staining was performed on paraffin-embedded samples. 
After paraffin embedding removal using xylene, and samples re-hydratation by means of a graded 
concentration ethanol scale, samples were rinsed in water and a procedure of antigen retrieval was 
done. For antigen retrieval samples were maintained in sodium citrate buffer (10 mM sodium citrate 
containing 0.05% Tween 20, pH 6) and underwent four 4 seconds-cycles of heating in a microwave 
oven at 800W, separated by 1min of cooling. Samples were then rinsed in PBS containing 0.05% 
Tween 20 and processed for immunostaining using Tyramide Signal Amplification kit (Thermo 
Scientific, Rockford, Illinois) following manufacturer’s instructions, with exception for nonspecific 
antigenic sites blockage that was done overnight at 4°C. 
 
Total RNA purification, retrotranscription and qRT-PCR 
For total RNA extraction we cultured cells in 60 mm Petri dishes as described above. Cells 
were then harvested maintaining samples on ice, centrifuged for 5min at 4,000 rpm and 4°C and 
resuspended in appropriate volume (1 mL for cells derived from a 60 mm Petri dish) of TriFast 
reagent (Euroclone, Pero, Milan). RNA, DNA and protein separation was obtained by adding 
chloroform in a 1:5 volume ratio, followed by incubation at RT and centrifugation for 15min at 
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12.000xg. The hydrophilic fraction was collected and RNA was concentrated by sequential 
precipitation using 2-propanol and washes with ethanol 75% in diethylpyrocarbonate (DEPC)-
treated water. Finally, RNA was rinsed in DEPC-water and concentration and purity were 
determined by analysis at the spectrophotometer. The following RNA retrotranscription and qRT-
PCR reactions were done using Exiqon miRCURY LNA™ Universal RT microRNA PCR Starter 
Kit (Exiqon, Vedbaek, Danmark) following manufacturer’s instructions, except for sample volumes 
which were 20 µL both for retrotranscription (final concentration 1 µg/µL) and qRT-PCR reactions. 
For qRT-PCR amplification cDNA templates were diluted 1:20 (Oli-neu RNA extracts) and 1:40 
(fibroblasts RNA extracts). PCR amplification and samples analysis were done using a 
QuantStudio5 Thermocycler and QuantStudio5 software (Applied Biosystems, Foster City, 
California). 
 
Image acquisition and analysis 
We acquired immunofluorescence micrographs using a Nikon E600 microscope, a Ziess 
Axiovert 200 confocal microscope equipped with a Perkin Elmer UltraVIEW acquisition system, or 
a Zeiss LSM510 Meta microscope, and by means of Zeiss plan-NEOFLUAR 63x or 40x objectives. 
When multiple staining were done images from different emission specters were acquired 
separately and superimposed in the aftermath. When images had to be compared we used the same 
parameters of acquisition. Images were exported as TIFF files and Photoshop (Adobe Systems, 
Mountain View, CA, USA) and ImageJ software were used for following processing and analysis. 
GPR17 distribution in endocytic compartments was quantified by measuring the intensity of αNt-
GPR17 and αFLAG immunostaining in samples fixed before UDP-Gluc stimulation, after receptor 
internalization and glycine washes, and finally after incubation at 37°C in the absence of agonist. 
Cells expressing comparable levels of transfected proteins were chosen for analysis. Results are the 
mean of at least three independent experiments for each condition and approximately 100 cells for 
each experiment were analyzed. For the quantification of GPR17 and CC1-positive cell number in 
brain hemispheres, images were acquired at 10X magnification using a Zeiss Axiovert 8400 
microscope equipped with a CCD camera. ImageJ was used to count cells, whose number was then 
normalized on the number of counted fields. At least 50 fields (869,14 µm wide and 650,28 µm 
high) for each sample were examined (total area 565,186.5 µm2). The quantification of MBP and 
MAG expressing cell number and of MBP immunoreactivity in brain sections was done on stitched 
composite images acquired using the stitch option of Volocity acquisition system. Zeiss Plan-
NEOFLUAR 25x/0.80 objective and PRIOR Proscan 3 motorized xy-stage were used for sample 
scanning. For the analysis of MBP in brain hemispheres, comparable sections were chosen. The 
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whole hemispheres were automatically acquired and stitched using Volocity software and a focus 
map created for acquisition of the best focus for each field. Composite stitches images were then 
exported as TIFF files, processed and analyzed using Photoshop and ImageJ. Selected areas of 
cortex and corpus striatum were converted in binary images using an automatic thresholding 
function of ImageJ software and quantification was done on approximately equal areas: 4.95 mm2 
and 5.07 mm2 respectively for euploid and Ts65Dn in the cortex, while for the corpus striatum the 
analyzed area was of 5.90 mm2 for both euploids and Ts65Dn. 
 
Statistical analysis 
GraphPad Prism software was used for statistical analysis. When two treatments were 
compared the results from independent experiments were collected as raw quantitative data and 
used to calculate mean values, that were then subjected to two-tailed unpaired Student’s t-test to 
assess statistical significance. One-way ANOVA with Tukey’s test was used when comparing three 
or more groups. Results are expressed as percentage of control samples, apart for degradation assay 
for which we used t=0 control set to 100% for normalization, and rescue experiment for which we 
used shSCR/pcDNA3 co-transfected sample set to 100% for normalization. With exception for 
preliminary data regarding the effects of mir-155 overexpression on OL differentiation (Fig. 14B), 
for which statistical significance is not reported, at least three independent experiments were 
conducted for each analysis. The exact number of experiments conducted for each analysis is 
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RESULTS 
A PDZ-binding motif is specifically required for endosomes to plasma 
membrane recycling of GPR17 
Our preliminary data suggested the involvement of the GPR17 PDZ-binding motif in the 
control of receptor endocytic trafficking. To understand in detail the function of this domain, we 
decided to define which endosomal pathway the PDZ-binding motif mutation disrupts. We took 
advantage of the receptor in vivo labeling with αNt-GPR17 antibody to track the endocytosis and 
endosomal sorting of wild type GPR17 (GPR17-wt) and GPR17-SELA mutant (Table 2) and then 
compared receptor transport by immunofluorescence staining and confocal microscopy imaging. 
HEK293 were transiently transfected with the two GPR17 isoforms. Labeling of live cells with αNt-
GPR17 was performed 48hr later to allow protein expression. For this analysis labeling was 
performed at 4°C to maintain cell metabolism blocked and avoid constitutive internalization of 
labeled receptors (Fratangeli at al., 2013). Notably, quantification of receptor immunoreactivity 
revealed no significant differences between the amounts of GPR17-wt and SELA present in the 
plasma membrane of transfected cells (Fig. 1A, E and I). This result indicates that comparable 
amounts of GPR17-wt/GPR17-SELA are delivered to the cell surface demonstrating that GPR17 
synthesis and transport through the biosynthetic pathway are not affected by mutation of the PDZ-
binding motif. Thus, we speculated that PDZ-binding motif disruption affected GPR17 
internalization and/or transport through the endocytic pathway. To test this hypothesis we 
stimulated GPR17 endocytosis by incubating transfected HEK293 cells (after labeling at 4°C with 
αNt-GPR17) at 37°C in DMEM medium containing 100 µM GPR17 agonist UDP-Gluc (Fratangeli 
et al., 2013). After 30min, UDP-Gluc containing medium was removed and cells were washed with 
acid glycine buffer (pH 2.8) to strip antibodies bound to receptors still present at the cell surface. 
Samples were then fixed and processed for immunofluorescence staining with an anti-rabbit IgG 
conjugated to Cy2. Analysis of immunofluorescence micrographs showed that upon agonist-
induced endocytosis GPR17-wt and GPR17-SELA were both detected in intracellular vesicles (Fig. 
1B and F), in line with our previous data showing that upon stimulation GPR17 is rapidly 
internalized in EE where partially co-localizes with TfR (Fratangeli et al., 2013 and preliminary 
results). Interestingly, quantification of receptor immunoreactivity using ImageJ software indicated 
there was no significant difference between the amounts of internalized GPR17-wt and GPR17-
SELA (Fig. 1L). This result leaded us to conclude that GPR17 PDZ-binding motif disruption did 
not alter receptor internalization. We then allowed internalized receptors to distribute into 
endosomal compartments by incubating cells in the absence of UDP-Gluc for either 10 or 20 min 
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(37°C, 10% CO2), times previously described to allow GPR17 sorting into either degradative or 
recycling pathways (Fratangeli et al., 2013). Accordingly, already after 10min intracellular GPR17-
wt staining was significantly reduced due to receptor transport to lysosome or recycling to plasma 
membrane. On the contrary GPR17-SELA was retained into intracellular compartments for a longer 
period than GPR17-wt (Fig. 1C, D, G and H). Quantification of immunofluorecence intensities 
confirmed that ~30% more GPR17-SELA than wt receptor was still present inside the cells 20min 
after agonist removal (Fig. 1L). These results, together with a growing number of evidences 
showing that PDZ-binding motifs are involved in the regulation of GPCR recycling (Romero et al., 
2011), leaded us to speculate that the C-terminal PDZ-binding motif is required for GPR17 
recycling to the plasma membrane. 
To definitively clarify this aspect we took advantage of an isoform of GPR17 expressing a 
Flag-tag epitope in the extracellular domain (FLAG-hGPR17-wt) and mutagenized it to add a C-
terminal alanine (FLAG-hGPR17-SELA; Table 2). This allowed us to repeat the above described 
experiment and follow the endocytic transport of GPR17 in live cells using a monoclonal antibody 
directed against the Flag-epitope (αFLAG antibody) with a stronger affinity for antigen compared to 
αNt-GPR17. Using αFLAG antibody we were able to unveil that internalized FLAG-hGPR17-wt 
was partially recycled to the plasma membrane once cells were re-incubated at 37°C upon UDP-
Gluc removal and glycine-buffer washing. On the contrary, almost no GPR17-SELA was re-
exposed at the cell surface (Fig. 2C and C’). 
Taken together, these results demonstrate that GPR17 PDZ-binding motif is required for 








Figure 1. GPR17-SELA is retained intracellularly after agonist removal. 
A, E Representative immunofluorescence micrographs showing surface GPR17 labeling of 
HEK293 cells with affinity-purified αNt-GPR17 after transfection with either GPR17-wt or GPR17-
SELA. B, F Representative immunofluorescence micrographs showing internalization of GPR17-wt 
or SELA. Upon stimulation with 100 µM UDP-Gluc, cells were washed with glycine buffer (pH 
2.8) to remove antibodies bound to the remaining cell surface-exposed receptors, and then fixed (0 
min). C, D, G, H Representative immunofluorescence micrographs showing that more GPR17-
SELA than wt receptors are retained in the cells following 10 and 20 min of agonist removal. A-H 
Scale bar: 10 µm. I Quantitative analysis of the intensity of GPR17 immunoreactivity detected on 
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plasma membrane of transfected cells after labeling (see A and E panels) as determined using 
ImageJ software. The values are expressed as arbitrary units and represent the mean value ± s.e.m., 
n=10 cells transfected with GPR17-wt and 12 cells transfected with GPR17-SELA. L Quantitative 
analysis of the intensity of GPR17 immunoreactivity in transfected cells at 0, 10 and 20 min after 
agonist removal. The data are expressed as the percentage of immunoreactivity detected after 
agonist-induced internalization (time 0 set to 100%). The mean value ± s.e.m. detected in 93 
(0min), 79 (10min), and 104 (20min) GPR17-wt transfected cells or 113 (0min), 110 (20min) and 
98 (20min) GPR17-SELA transfected cells are shown. ***P=0.0007; **P=0.0051 unpaired two-
















Figure 2. The recycling of GPR17-SELA is impaired. 
A-C’ Representative micrographs of HEK293 cells transfected with FLAG-hGPR17-wt or FLAG-
hGPR17-SELA showing: A, A’ the surface localization of wt and mutant GPR17 after labeling at 
4°C with a monoclonal antibody against the Flag epitope; B, B’ GPR17 intracellular staining after 
UDP-Gluc stimulation and C, C’ 15min after agonist removal. Note in C recycling of wt receptor to 
the cell surface (arrows) whereas FLAG-hGPR17-SELA is mainly retained in the cells (C’, arrow 
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SNX27 interacts with GPR17 at the level of endosomal compartments 
 By means of pulldown experiments we had obtained preliminary evidences suggesting an 
interaction between SNX27 and the C-terminal domain of GPR17 (Prel.Fig. 3). SNX27 is an 
accessory protein of the retromer complex shown to mediate recruitment of cargos expressing a 
type I PDZ-binding motif, and their sorting into endosomal tubular-domains committed to 
membrane recycling (Temkin et al., 2011). To further demonstrate a role for SNX27 in the 
regulation of GPR17 intracellular trafficking we confirmed its expression in primary cultures of 
OLs. To this aim, Oli-neu and primary OL cultures were fixed and then double-immunolabeled 
using antibodies directed against SNX27 and OL lineage markers such as OLIG2. Images obtained 
with a spinning disk confocal microscope revealed that SNX27 is expressed by oligodendroglial 
cells where it decorates intracellular dot-like structures distributed in the cytoplasm and in the 
perinucleral region (Fig. 3), a pattern in line with that reported in literature (Joubert et at., 2004; 
Lauffer et al., 2010). 
 We then asked whether SNX27 and GPR17 co-localize at these intracellular vesicles (i.e. 
early/recycling endosomes). To address this issue we again used αNt-GPR17 antibody to label 
endogenous GPR17 in live Oli-neu or primary OLs, and to detect receptor distribution in the 
endosomal pathways. Oli-neu or OPCs were exposed to CM or neurobasal medium (Fumagalli et 
al., 2011) to induce cells differentiation and GPR17 expression. We then labeled at 4°C cell-surface 
receptors of living cells and either i) incubated samples at 37°C to track GPR17 constitutive 
endocytic trafficking (Fratangeli et al., 2013); or ii) stimulated receptor endocytosis using UDP-
Gluc and allowed endosomal distribution by incubating cells at 37°C 10% CO2 in the absence of the 
agonist. We finally washed cells with glycine buffer and fixed samples. Cells were then double-
immunolabeled with a goat polyclonal anti-SNX27 antibody (followed by an anti-goat biotin-
conjugated antibody and a streptavidin conjugated to Cy2) and anti-rabbit IgG conjugated to Cy3 to 
detect GPR17. Images acquired by confocal microscopy clearly showed that upon constitutive (Fig. 
4C) or agonist-mediated internalization (Fig. 4A and B) GPR17 and SNX27 co-localize in vesicular 
structures scattered in the cytosol of Oli-neu and primary differentiating OPCs. These findings, 
joined to the previous evidences obtained by pulldown analysis (Prel.Fig. 3), strongly suggested 
SNX27-GPR17 interaction in OL endosomes. 
 
 To gain more insights on the mechanistic details of GPR17-SNX27 binding, we cloned 
SNX27 cDNA into a pRSET B vector and used the construct to transform BL21DE3 E. coli 
bacteria and purify SNX27 from bacteria extracts. SNX27 expression was induced using IPTG. In 
order to purify the protein, we took advantage of a poly-histidine tag at the N-terminal of SNX27, 
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which results from its cloning into pRSET B vector backbone. Nickel-conjugated resin beads were 
then used to separate histidine-tagged SNX27 (his-SNX27) from bacteria lysates. His-SNX27 was 
eluted in phosphate saline buffer (PBS) and incubated with either CT and ΔCT peptides (Fig. 5A). 
After extensive washing we eluted bound proteins with glycine buffer (pH 2.2) and analyzed 
purified his-SNX27 affinity for CT and ΔCT peptides by Western blotting. As reported in figure 5, 
while we detected his-SXN27 in samples eluted from CT resin, his-SNX27 was not isolated by 
ΔCT peptide (Fig. 5C), suggesting a direct interaction between SNX27 and GPR17 C-terminal. 
 Based on the observation reported by Lauffer and colleagues who demonstrated that 
mutation of histidine residue 112 in SNX27 PDZ binding grove disrupts the interaction with β2AR 
receptor (Lauffer et al., 2010), we decided to test whether PDZ domain disruption affects also 
interaction with GPR17. This histidine residue is supposed to coordinate the hydroxyl group of S/T 
residue P-2 of type I PDZ-binding motif (Fig. 5B and Hanyaloglu and von Zastrow, 2008), but 
differently from murine SNX27, in SNX27 human orthologue (which we used in our experiments) 
H112 is found at position 114 (H114). Thus, we mutagenized H114 by substitution with an alanine 
(his-SNX27-H114A) and analyzed its interaction with GPR17 C-terminal by pulldown. Results 
clearly showed that H114 disruption abolished his-SNX27 isolation with CT peptide (Fig. 5D), 
demonstrating that interaction specifically occurs between the GPR17 PDZ-binding motif and the 













Figure 3. SNX27 is expressed in cells of the OL lineage. 
A, B Representative micrographs showing the distribution of SNX27 in undifferentiated Oli-neu 
cells after labeling with a polyclonal antibody directed against SNX27. C Primary OL cultures were 
double-immunolabeled with antibodies against SNX27 and the TF OLIG2. Note that SNX27 shows 
a punctate intracellular distribution. Scale bars: 10 µm. 
 
 






Figure 4. Endocytosed GPR17 co-localizes with SNX27 in early endosomes. 
A-C Representative immunofluorescence micrographs showing co-localization of SNX27 with 
endogenous GPR17 after internalization. Oli-neu cells (A) and primary OPC cultures (B, C), after 
differentiation in immature oligodendroglial cells, were incubated at 4°C with affinity-purified αNt-
GPR17 antibodies and then either unstimulated (C) or stimulated with 100 µM UDP-Gluc (A and 
B). Cells were then washed with glycine buffer to remove labeling from plasma membrane 
receptors, fixed and double-immunostained with an anti-rabbit IgG conjugated to Cy3 to detect 
GPR17, and a goat polyclonal antibody against SNX27. Merged images are shown in A, a, B, b and 
C/c. Note that GPR17 partially co-localizes with SNX27 in vesicles scattered in the cytoplasm 
(arrows). Scale bars: A, c’’=5 µm; a’’=1 µm. 
 







Figure 5. Interaction in vitro of GPR17 PDZ-binding motif and SNX27 PDZ domain. 
A Schematic representation of peptides corresponding to the C-terminal tail of GPR17 with (CT) or 
without (ΔCT) the PDZ-binding motif, conjugated to Sepharose 4B resin beads and used in 
pulldown experiments. B Schematic representation of the SNX27-PDZ region and position of the 
His114 residue mutagenized to alanine (his-SNX27-H114A or H/A). C, D CT or ΔCT beads (10 µL) 
were incubated with purified his-SNX27 (C) or lysates from BL21DE3 (D) expressing wild-type 
his-SNX27 (WT) or his-SNX27-H114A (H/A). Proteins eluted from the Sepharose matrices and 
aliquots of purified his-SNX27 or bacterial lysates (input) were analyzed by Western blotting. Blots 
representative of three independent experiments are shown. 
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SNX27 regulates GPR17 recycling and levels of expression 
 Given the role of GPR17-PDZ binding motif in receptor recycling and its interaction with 
SNX27, we asked whether SNX27 has a role in GPR17 recycling to the plasma membrane. To 
address this issue we used a short-hairpin RNA (shRNA) targeting SNX27 mRNA to silence 
SNX27 expression and analyze the effects on GPR17 trafficking. In preliminary experiments we 
tested four constructs expressing GFP as a reporter gene and distinct shRNAs targeting different 
sequences of SNX27 mRNA. We selected the construct that had the highest efficiency in down-
regulating SNX27 (SNX27 was reduced to 33.36%±14.44% with respect to shRNA-scrambled 
transfected control set to 100%; Fig. 7A). For the analysis of GPR17 trafficking, Oli-neu cell line 
was used as a more physiological model in respect to HEK293 cells. However, on the hypothesis 
that altered endosomal sorting of GPR17 between recycling and degradation in lysosome would 
lead to an increased degradation of GPR17 (as observed for other receptors; Lauffer at al., 2010), 
we co-transfected Oli-neu with FLAG-hGPR17-wt and shRNA-SNX27 or shRNA-scrambled 
(shRNA-Scr, control). 48hr later live cells were labeled at 4°C using αFLAG antibody, incubated 
with UDP-Gluc to promote internalization of labeled receptors and washed with acid glycine. 
Finally, we allowed endosomal sorting of labeled receptors by re-incubating cells at 37°C in the 
absence of UDP-Gluc. Cells were fixed during the different steps of the experiment (i.e. labeling, 
internalization and UDP-Gluc removal) and analyzed by immunofluorescence. αFLAG antibody 
was detected using anti-mouse IgG conjugated with Cy3 fluorophore, while we used a polyclonal 
anti-NG2 antibody to decorate cell membrane. Examination of immunofluorescence micrographs 
and quantitative analysis of fluorescence intensities were conducted on cells expressing comparable 
amounts of GFP. Quantitative analysis of GPR17 immunoreactivity revealed that comparable levels 
of GPR17 were labeled at cell surface (Fig. 6A a-a’’ and d-d’’) and internalized after UDP-Gluc 
stimulation (Fig. 6A b-b’’, e-e’’ and B) in shRNA-SNX27 and shRNA-Scr transfected cells. On the 
other hand, 15min after UDP-Gluc removal, we saw a redistribution of FLAG-hGPR17-wt staining 
from intracellular compartments to the plasma membrane in scrambled-transfected control, also 
confirmed by co-localization with NG2 proteoglycan (Fig. 6A c-c’’ arrows, and B). This 
redistribution (i.e. recycling) was almost completely abolished by SNX27 silencing, leading to 
increased FLAG-GPR17-wt retention into intracellular compartments (Fig. 6A f-f’’, and B). These 
observations strongly suggested that SNX27 is required for GPR17 recycling to the plasma 
membrane. 
 
 Once internalized in the EE receptors may undergo sorting to different pathways. The 
LE/lysosome pathway, however, seems to be the dominant destiny of cargos that prolong their stay 
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in EE because are not transported into other membrane micro-domains committed to different 
pathways (Gruenberg J., 2001; Hanyaloglu and von Zastrow, 2008). As already described in 
previous works for β2AR and glutamate receptors, by inhibiting receptor recycling, SNX27 down-
regulation could result in an accumulation of cargos in the EE that ultimately leads to their sorting 
to lysosomal degradation (Lauffer et al., 2010; Wang et al., 2013). To test this hypothesis also for 
GPR17 we transfected Oli-neu cells with either shRNA-Scr or shRNA-SNX27 and, 24hr after 
transfection, differentiate cells using CM. Oli-neu exposure to CM promotes cell exit from 
proliferating state and entering in the differentiation process. Differentiating Oli-neu express 
GPR17 in a manner that resembles that of OPCs during differentiation. In particular, GPR17 
reaches the peak of expression within 48hr after exposure to CM (refer to “Cell culture” paragraph 
in Materials and Methods and Meth.Fig. 1). We therefore decided to evaluate GPR17 expression 
levels at this time point. Thus, after transfection and differentiation, samples were lysed and 
processed for immunoblotting analysis. Interestingly, we found a reduction of nearly 50% 
(49%±8.64% with control set to 100%; n=3 independent experiments) in GPR17 amounts in 
shRNA-SNX27-transfected samples in comparison to shRNA-Scr controls, suggesting that SNX27 
silencing affects GPR17 expression stability (Fig. 7A). Notably, no changes were found in proteins 
known to undergo intracellular trafficking and recycling but that do not express a PDZ-binding 
motif (cadherins; Le et al., 1999) and also in markers of cellular structures known to be required for 
intracellular trafficking (i.e. actin cytoskeleton and the GS28 marker of Golgi apparatus) (Fig. 7A). 
 These observations strengthened the assumption that only recycling pathway was impaired 
by SNX27 silencing. As a further confirm that GPR17 decrease was, at least partially, due to an 
increased sorting to lysosome we try to rescue GPR17 levels using ammonium chloride (NH4Cl), a 
known inhibitor of lysosome-associated protease activity. Results indicated that treatment with 
NH4Cl determined increased levels of GPR17 in both SNX27-silenced and control samples, but a 
significantly higher increase was observed in samples down-regulated for SNX27, demonstrating 
that an higher rate of receptor sorting into the degradative pathway was present (Fig. 7B). 
Finally, we tested whether rescue of SNX27 expression caused a recovery of GPR17. To 
this aim we co-transfected shRNA-SNX27 or scrambled control with the human isoform of SNX27 
(hSNX27-Myc). This isoform carries single-nucleotide-polymorphisms (SNPs) in the sequence 
targeted by shRNA-SNX27 and is shRNA-insensitive (data not shown). Western blot analysis of 
GPR17 expression confirmed a partial, although significant, recovery of receptor levels with respect 
to samples co-transfected with shRNA-SNX27 and pcDNA3 vector backbone used as a control 
(Fig. 7C). Data are expressed as a percentage of shRNA-Scr/pcDNA3 co-transfected samples set to 
100%. 
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 Taken together these observations demonstrate that GPR17 recycling is specifically 









Figure 6. SNX27 down-regulation inhibits GPR17 recycling 
A Oli-neu cells were co-transfected with plasmids encoding FLAG-hGPR17 and shRNA-SNX27 or 
shRNA-Scr. Cells were fixed i) after labeling at 4°C with the αFLAG antibody (Labeling, a-a’’, d-
d’’), or ii) after a subsequent incubation with UDP-Gluc followed by glycine washing (UDP-Gluc 
stim, time 0 min; b-b’’, e-e’’), or iii) after agonist removal (UDP-Gluc removal, time 10 min; c-c’’, 
f-f’’). Cells were then double-immunolabeled with anti-mouse IgG conjugated to Cy3 to detect 
FLAG-hGPR17, and with an anti-NG2 antibody to decorate plasma membranes. 
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Immunofluorescence micrographs show that in co-transfected Oli-neu (identified by GFP and 
FLAG immunolabeling) and expressing a scrambled shRNA, FLAG-hGPR17 is re-exposed to the 
cell surface (c-c’’, arrows). On the contrary in cells silenced for SNX27, FLAG-hGPR17 is not 
recycled to the plasma membrane (f-f’’). Scale bar = 10 µm. B Cells with similar GFP intensity 
were acquired and subjected to quantitative analysis. The graphs show the quantification of the 
intensity of immunoreactivity detected inside the cells and at the cell membrane after UDP-Gluc 
stimulation (UDP-Gluc stim, time 0) or after stimulation followed by 10min of agonist removal. 
The data are expressed as the percentage of total immunoreactivity (plasma membrane plus 
intracellular staining set to 100%) detected after each selected time point and are the mean values ± 
s.e.m. of 25 to 32 transfected cells for each condition from two experiments. ***P<0,001 two-tailed 
unpaired Student’s t-test. 
 
 




Figure 7. SNX27 knock-down affects the stability of GPR17. 
A SNX27 silencing significantly reduces the levels of GPR17 in Oli-neu cells transfected with 
shRNA-SNX27 or scrambled shRNA. After transfection followed by incubation in CM to induce 
differentiation and GPR17 expression, cells were homogenized and protein extracts analyzed by 
Western blotting. Blots representative of three independent experiments are shown. For quantitative 
analyses, the signal intensity of the different proteins was standardized to the signal intensity of 
actin and expressed as a percentage of the amount of protein detected in shRNA-Scr (control, 
100%). Mean values ± s.e.m. are shown (n=3; *P=0.011, **P=0.0042 unpaired two-tailed Student's 
t-test). B Oli-neu cells expressing shRNA-Scr or shRNA-SNX27 were pre-incubated for 1hr with 
cycloheximide (500 µM) and then 30min with UDP-Gluc (100 µM), followed by 30min of 
recycling in the presence (+) or absence (−) of NH4Cl (20 mM) to block lysosomal degradation. 
	   70	  
Samples were analyzed by Western blotting. Mean values ± s.e.m., n=3 are indicated; P values were 
calculated using one-way ANOVA with the Tukey test: *P<0.05; ***P<0.001. C Oli-neu cells were 
transfected either with shRNA-Scr or shRNA-SNX27 and the empty pcDNA3 vector or with 
shRNA-SNX27 and a plasmid encoding a shRNA-insensitive isoform of SNX27. Cell extracts were 
analyzed by Western blotting. For quantification we measured the signal intensity of the different 
proteins and standardized values on the signal intensity of actin. Results are expressed as a 
percentage of the amount of protein detected in shRNA-Scr/pcDNA3 co-transfected control set to 
100%. Mean values ± s.e.m. are shown (n=4; **P<0.01, unpaired two-tailed Student's t-test). 
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SNX27 is required for the correct kinetics of OL differentiation 
 Given the important role of GPR17 in OL differentiation (Chen et al., 2009; Fumagalli et al., 
2011), and our results describing the role of SNX27 in the recycling of GPR17, we decided to 
investigate whether SNX27 disregulation may have some implications on OL differentiation. To 
address this issue we took advantage of Oli-neu cell model, a well-characterized in vitro system for 
the study of OL differentiation (Fratangeli et al., 2013; Simon et al., 2016). Oli-neu is a cell line 
derived from murine OPCs immortalized by an activated neu tyrosine kinase (Jung et al., 1995). As 
previously described (see Materials and Methods) when cultured in Sato medium Oli-neu remain in 
a proliferating condition and do not undergo differentiation. Under this condition undifferentiated 
Oli-neu express very low levels of GPR17 and no myelin proteins (Meth.Fig. 1 and Fratangeli et al., 
2013). On the other hand, when exposed to CM, Oli-neu begin to differentiate toward a more 
mature phenotype following the different phases of physiological OL differentiation (Fratangeli et 
al., 2013). GPR17 is a well-established marker of differentiation transition from committed OPCs 
(NG2+ O2+ O4+ MBP- cells) to pre-myelinating (PLP/DM20+ MBP- cells) OLs (Boda et al., 2011). 
A similar expression pattern is also observed during Oli-neu differentiation: when exposed to CM, 
Oli-neu begin to express GPR17 and its expression increases until reaches a peak between 48 and 
72 hr of differentiation. At these time points nearly 90% (48hr) or 70% (72hr) of the cells are 
GPR17-positive (Meth.Fig. 1). As observed in in vivo OL differentiation (Boda et al., 2011), 
GPR17 expression in Oli-neu is then down-regulated in concomitance with cell entrance in the 
terminal maturation phases and the expression of myelin proteins MAG and MBP. Given the well-
established kinetics of Oli-neu differentiation, we compared the differentiation of cells transfected 
with either shRNA-SNX27 or shRNA-Scr by measuring the levels of GPR17 and myelin proteins. 
After transfection, cells were exposed to CM and examined after 48hr, a time point when high 
levels of GPR17 and low MBP/MAG expression are expected. As reported in figure 8, images, 
acquired by means of a spinning disk confocal microscope, showed that scrambled-transfected 
control cells (identified by GFP expression) exhibited a branched morphology and expressed high 
levels of GPR17, while did not co-express MAG and MBP myelin markers. This is in line with a 
pre-myelinting stage of differentiation, as also previously reported (Fig. 8A a-b’’; Fratangeli et al., 
2013). On the contrary, GPR17 expression was significantly reduced in shRNA-SNX27-transfected 
cells, paralleled by a higher expression of both MBP and MAG myelin proteins (Fig. 8A c-d’’). 
Specifically 33.6%±2.57% of GFP-expressing cells were MBP-positive in SNX27-silenced samples 
while 12%±2.86% MBP-positive cells were counted in control (Fig. 8B). Quantitative analysis of 
MAG expression by Western blotting of cell extracts also confirmed a 4-fold increase of MAG 
levels in SNX27-silenced samples with respect to scrambled-treated cells (control) (Fig. 8C). These 
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data suggest that in differentiating Oli-neu SNX27 knock-down and consequent GPR17 down-
regulation (due to lysosomal degradation) correlate with a precocious entering of pre-myelinating 
OLs in the myelinating phase. 
 To translate these results in a more physiological model, we repeated this analysis in 
primary cultures of OPCs. Western blot analysis of differentiated OPC extracts confirmed a 
significant reduction of GPR17 expression (69.77±8.39) in samples knocked down for SNX27 
compared to controls (Fig. 8D). This was accompanied by an increased trend in the number of 
MAG-expressing cells that we found in shRNA-SNX27-transfected samples in respect to scrambled 
control, as revealed by confocal microscopy (Fig. 8D), suggesting a precocious expression of 
myelin markers, in accordance with what observed for Oli-neu cell line. 
 Overall, these observations indicate that loss of SNX27 results in GPR17 down-regulation 
and concomitant accelerated OL maturation in Oli-neu and differentiating OPCs. 
 
 We further investigated the effects of SNX27 knock-down on OL development by analyzing 
the activation of pathways associated to OL differentiation and GPR17 signaling. In particular, the 
levels of GRK2, of mTOR (mammalian Target of Rapamicin) and its activated form phospho-
mTOR (Tyler et al., 2011), and the nuclear/cytosolic localization of Id2 TF (Chen et al., 2009) were 
analyzed in either shRNA-SNX27 or shRNA-Scr transfected Oli-neu. mTOR/GRK2 pathway was 
shown to control both GPR17 endocytosis and downstream signaling (Tyler et al. 2011; Daniele et 
al., 2014; Fumagalli et al., 2015) while Id2 is a known inhibitor of OL maturation, which was also 
suggested to mediate GPR17 effects (Chen et al., 2009). Our analysis revealed no significant 
alterations in mTOR pathway activation or GRK2 expression between shRNA-SNX27-transfected 
and control samples (Fig. 9A). However, we observed a redistribution of Id2 TF from the nucleus to 
the cytosol in SNX27-silenced cells (23.48%±5.53% nuclear; 76.93%±5.94% cytosolic) compared 
to shRNA-Scr-transfected controls (44.77%±0.70% nuclear; 55.23%±0.71% cytosolic; n=2 
independent experiments) (Fig. 9B). These results further sustain the hypothesis that down-
regulation of GPR17 signaling pathway is at least one of the mechanisms responsible of accelerated 
OL differentiation kinetics observed upon SNX27 knock-down and suggest that Id2 nucleus to 
cytosol translocation may act as a downstream signal that allows OPC differentiation. 
 
 





Figure 8. SNX27 silencing accelerates OL differentiation. 
A Representative immunofluorescence micrographs showing elevated MAG and MBP expression 
concomitantly with GPR17 down-regulation in SNX27-silenced Oli-neu (shRNA-SNX27) 
compared to control cells (shRNA-Scr). B Quantitative analysis of immunolabeled cells 
demonstrated that the percentage of MBP-positive cells was significantly higher in shRNA-SNX27-
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transfected Oli-neu compared with shRNA-Scr-transfected cells. Mean values ± s.e.m., n=505 cells 
transfected with shRNA-Scr and 523 cells transfected with shRNA-SNX27 were examined. 
**P=0.005, two-tailed unpaired Student's t-test. C Western blotting analysis using anti-MAG 
antibody of cell lysates (30 µg of proteins) of Oli-neu transfected with shRNA-Scr or shRNA-
SNX27 and the respective quantitative analysis (graph; mean values ± s.e.m. n=3, *P=0.042 two-
tailed unpaired Student's t-test). D SNX27 knock-down accelerates down-regulation of GPR17 and 
differentiation of OPCs. Primary mouse OPCs were transfected with shRNA-Scr or shRNA-
SNX27, induced to differentiate, and analyzed either by Western blotting or immunofluorescence. 
Quantitative analysis of Western blots revealed a significant decrease of GPR17 in cultures after 
SNX27 silencing (mean values ± s.e.m., n=3, *P=0.012 two-tailed unpaired Student's t-test), 
whereas an increased number of MAG-expressing cells was detected in OPC cultures transfected 
with shRNA-SNX27. Mean values ± s.e.m., n=1170 cells transfected with shRNA-Scr and 1226 
cells transfected with shRNA-SNX27. *P =0.050, two-tailed unpaired Student's t-test. 
 
 








Figure 9. SNX27 silencing modifies the nuclear/cytoplasmic distribution of Id2 but does not 
affect the mTOR and GRK2 levels. 
A Equal amounts of cell extracts (30 µg) from Oli-neu cells transfected with either shRNA-Scr or 
with shRNA-SNX27 were analyzed by Western blotting. No changes were detected in GRK2 
expression, and in the phosphorylation/activation of mTOR at Ser2448. One representative 
experiment is shown. B Cytoplasmic (Cyto) and nuclear (Nucl) fractions were prepared from 
transfected Oli-neu cells. Equal amounts of proteins were subjected to Western blotting analysis 
with antibodies against GAPDH, GFP and Id2. 
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Altered OL differentiation and myelin defects in Ts65Dn mouse model 
of DS correlate with a decrease of SNX27 levels 
 Recent studies in human DS brains and Ts65Dn mouse brains (the most used murine model 
of DS; Reeves et al., 1995) have demonstrated that trisomy-linked overexpression of mir-155 and 
consequent down-regulation of C/EBPβ, a TF required for the expression of SNX27, result in 
reduced levels of SNX27 (Wang et al., 2013). SNX27 deficiency was shown to alter synaptic 
transport of AMPA and NMDA receptors which finally contributes to the cognitive impairment 
observed in DS patients (Wang et al., 2013). Based on these observations we thought to be 
interesting to analyze GPR17 expression and OL differentiation in DS using the Ts65Dn model. 
Firstly, we confirmed literature data and found SNX27 deficit in Ts65Dn hippocampal extracts 
compared to euploid controls (Fig. 10A). Moreover, by means of qRT-PCR and Western blot 
analysis, respectively, we showed mir-155 overexpression and defective levels of SNX27 in 
primary cultures of fibroblasts derived from post-mortem trisomic human embryos compared to 
euploid controls (Fig. 10B and C). This suggests an inter-species and inter-tissue conservation of 
the mir-155/ C/EPBβ / SNX27 regulatory pathway described in Ts65Dn by Wang and colleagues 
(Wang et al., 2013). In collaboration with the laboratories of Prof. R. Bartesaghi (University of 
Bologna) and Prof. S. Ceruti (Università degli Studi di Milano), we then analyzed GPR17 
expression and OL development by immunolabeling of coronal sections of brain hemispheres from 
45-days-old Ts65Dn and euploid mice. Firstly, the total number of oligodendrocytes was examined 
by immunostaining of OLIG2 TF, which is broadly expressed in oligodendroglial lineage and is one 
of the trisomic genes (Mitew et al., 2014). In all the areas analyzed (i.e. hippocampus, dorsal 
prefrontal cortex and thalamus) Ts65Dn mice expressed a higher number OLIG2-positive cells, 
indicating an overall increase of oligodendroglial cells (data not shown). Remarkably, despite a 
global increase in OLs, the number of GPR17-positive cells was significantly reduced in Ts65Dn 
brain, both in the whole hemisphere and in the thalamus and cortex, with a trend also in the 
hippocampus (Fig. 11A and B). 
 To continue our analysis we evaluated the levels of markers of more advanced stages of 
differentiation. As a first step we stained brain sections with anti-CC1 antibody which is known to 
decorate mature OLs (Luo et al., 2014; Sachs et al., 2014). Analysis of immunolabeled sections 
showed a significant increase of CC1-positive OLs in trisomic brains, in the whole hemisphere as 
well as in the different examined areas (thalamus, dorsal prefrontal cortex, hippocampus, Fig. 11C 
and D). This result, together with the previously data on GPR17, demonstrates that, although the 
whole population of OLs is increased in trisomic brains, there is an alteration of OL development. 
Moreover, the analysis of OL differentiation in Ts65Dn brains suggested that an accelerated 
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maturation of OLs correlates with a decreased expression of GPR17 in brains characterized by low 
levels of SNX27. 
Despite these data, hypomyelination has been reported in human DS brains (Abraham et al., 
2012). Based on this observation we decided to evaluate the expression of MBP (a myelin protein 
expressed in more mature OLs than CC1 antigen; Boda et al., 2011; Zhang et al., 2014) in Ts65Dn 
brains. Remarkably, immunochemical staining of brain coronal sections followed by densitometric 
analysis revealed a significant decrease of MBP immunoreactivity, that involved both the white 
(corpus callosum; Fig. 12) and the grey matter (cortex and nucleus striatum; Fig. 13A-F). The result 
was also confirmed by Western blotting analysis of hippocampal extracts for both the two major 
isoforms of MBP protein (45% and 55% reduction of the 14kDa and 18.5/17kDa isoforms, 
respectively; Fig. 13G). 
 In conclusion our analyses showed that in Ts65Dn brain alterations in OL development lead 
to a final impairment of myelin formation. Deeper analyses are required to establish whether cell-
autonomous or non-cell-autonomous mechanisms (or a contribution of both) are responsible for the 
myelination deficits observed in DS and Ts65Dn brains. In addition, it would be also important to 
understand whether OL maturation in DS brains begins with a sustained shift towards proliferation 
followed by a partial maturation (as OLIG2 and CC1 increases suggest) and whether (and which) 











Figure 10. Levels of SNX27 are decreased in Ts65Dn mouse brains and human trisomic 
fibroblasts. 
A Left, Western blot analysis of SNX27 and actin expression in brain protein lysates of 3 animals 
per genotype (i.e., euploid and Ts65Dn). Right, quantitative analysis of SNX27 signal intensity 
normalized to actin and expressed as percentage of euploid brain (Eu: euploid; Ts: Ts65Dn). Mean 
values ± s.e.m. are shown; n=3 mice for each genotype; *P<0.05, unpaired two-tailed Student's t-
test. B, C Analysis of mir-155 and SNX27 expression in human euploid (Eu) and trisomic (DS) 
fibroblasts. B Total RNA extracts were prepared from primary cultures of either DS fibroblasts and 
euploid controls. Mir-155 expression was analyzed by qRT-PCR. Samples were analyzed in 
triplicates. The 2-ΔCt values obtained from euploid (Eu) or trisomic (DS) fibroblast were normalized 
on the amount of RNA spike-ins and are expressed as fold of increase over euploid (mean values ± 
s.e.m., ***P<0.0001). C Blots of SNX27 and actin immunostaining (left) and quantitative analysis 
(right) of SNX27 signal intensity normalized to actin and expressed as percentage of euploid. Mean 











Figure 11. Reduced expression of GPR17 correlates with increased expression of a marker of 
mature OLs in the brains of Ts65Dn mice. 
A, C Immunohistochemical analysis of GPR17 or CC1 in OLs (identified by co-localization with 
OLIG2) of brain slices from euploid and Ts65Dn mice. Scale bars = 100 µm. B, D Quantification of 
the number of GPR17-positive cells (B) and CC1-positive cells (D) in the whole brain hemisphere 
(left panels) and in selected brain areas (right panels). The number of cells was normalized to the 
total number of counted optical fields/condition. Results are the mean ± s.e.m., n=10 slices for 
GPR17 and 4 slices for CC1, from 4 animals each of euploid (Eu) and Ts65Dn (Ts) mice in the case 
of GPR17. *P<0.05 and **P<0.01, unpaired two-tailed Student’s t-test. 
 
 









Figure 12. Decreased expression of MBP in the corpus callosum of Ts65Dn mice. 
A, A’ Composite images of brain slices from euploid (A) and Ts65Dn (A’) mice immunostained for 
MBP and collected using an Axiovert 200 (Zeiss) confocal system equipped with a spinning disk. 
We exploited the stitch option of the Volocity acquisition setup and a motorized xy-stage (see 
Materials and Methods for details). The dotted white lines delimit the brain hemispheres. MBP 
immunoreactivity has been evaluated in the corpus callosum (i.e., the area between yellow dotted 
lines) by densitometric analysis with the ImageJ program. The white frames delimit the areas of 
cortex (CTX) and dorsal striatum (STRd) selected for further quantification (see Fig. 13). Scale bar 
= 1 mm. C Histogram shows MBP expression in the corpus callosum of euploid (Eu) and Ts65Dn 
(Ts) brains expressed as percentage ± s.e.m. of euploid set to 100%. 4 brain slices from 3 mice for 
each genotype have been analyzed. *P<0.05, unpaired two-tailed Student’s t-test. 
 
 






Figure 13. Decreased myelination in the cortex, dorsal striatum and hippocampus of Ts65Dn 
mice. 
A-D’ MBP expression was examined in regions of cortex (A, C) and dorsal striatum (B, D) (refer 
also to Fig. 12). The selected areas were converted in binary format (A’, B’, C’, D’) and the regions 
between the red lines were analyzed using ImageJ program. Six brain slices from three animals for 
each genotype were used and equal areas for cortex (CTX; euploid = 4.95mm2; Ts65Dn = 
5.07mm2) or dorsal striatum (STRd; euploid = 5.90mm2; Ts65Dn = 5.90mm2) were examined. 
Scale bar = 450 µm. E, F Histograms show the mean intensity ± s.e.m. of MBP expression as 
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percentage of euploid, n=6; *P<0.05, unpaired two-tailed Student’s t-test. G Western blotting 
analysis of MBP expression in the hippocampus. Left, hippocampal lysates from three animals for 
each genotype were analyzed by Western blotting. Right, histograms showing the quantification of 
the two major isoforms of MBP (polypeptides of 14kDa and 18.5/17kDa). Results are expressed as 
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mir-155 overexpression inhibits Oli-neu differentiation 
 To extend our analysis and begin to understand the mechanisms that underlie myelination 
impairment in DS, we decided to investigate the role of mir-155 in OLs. Analysis of online database 
reveled that it may targets a number of different genes expressed in oligodendroglial cells. As a first 
step, we analyzed mir-155 expression in undifferentiated and 48hr-differentiated Oli-neu by qRT-
PCR. Our results demonstrated that mir-155 is expressed in oligodendroglial cells, though at very 
low levels (Fig 14A). This observation is consistent with previous data showing mir-155 expression 
in human OPCs (Leong et al., 2014). Based on this result showing low levels of mir-155 in OLs, we 
speculated that was more informative to mimic the pathological conditions reported in DS patients, 
and thus we investigated the effect of mir-155 overexpression on Oli-neu differentiation. To this 
aim, we used a construct generated by O’Connel and colleagues that contains a mir-155 expressing 
cassette downstream of a GFP stop codon to allow concomitant expression of mir-155 and GFP, 
used as transfection reported gene (from here on referred to as pMGP155; O’Connel et al., 2009). 
The vector backbone was used as a control (pMGP). Oli-neu cells were transiently transfected with 
either pMGP or pMGP155 and induced to differentiate by exposure to CM. Samples were then 
processed for immunofluorescence or Western blot analyses. Confocal microscopy analysis, 
showed that mir-155 overexpressing cells (recognized by GFP expression) exhibited an altered cell 
morphology, with a less-branched shape and fewer thinner extensions compared to untransfected or 
pMGP-transfected controls (Fig. 14C). These morphological changes were accompanied by reduced 
levels of GPR17 (Fig. 14C) that did not correlate with increased expression of myelin proteins. On 
the contrary, expression of neither MAG nor MBP were observed in pMGP155-transfected cells 
(Fig. 14C and data not shown for MAG). Western blot analysis of 48 and 72 hr -differentiated cell 
extracts confirmed GPR17 and MAG down-regulation upon mir-155 overexpression (Fig. 14B), 
although in the specific case of GPR17, less pronounced difference was observed at 72hr of 
differentiation (Fig. 14B), when GPR17 constitutive expression is expected to diminish (Fratangeli 
et al., 2013). These results, though preliminary, suggest that mir-155 overexpression inhibits Oli-
neu differentiation, with cells maintained in an immature state that may precede GPR17 expression. 
This effect is different from that observed for SNX27 down-regulation. Accordingly, we did not 
find a reduction of SNX27 levels in mir-155 overexpressing samples compared to pMGP controls 
analyzed by Western blotting (Fig. 14B). 
 These data suggest that other, and jet to be determined, mir-155 target genes (beside 
C/EBPβ) may be involved in determining the impaired OL differentiation observed in DS brains. 
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Figure 14. Overexpression of mir-155 in Oli-neu induces down-regulation of GPR17 and 
myelin proteins in the early phases of differentiation. 
A mir-155 expression in undifferentiated and 48hr-differentiated Oli-neu was analyzed by qRT-
PCR. Total RNA extracts were prepared from Oli-neu cultured for 48hr in either Sato medium or in 
CM. Samples were then analyzed in triplicates. Values obtained by qRT-PCR amplification were 
expressed as 2-ΔCt using microRNA-103a (mir-103a) housekeeping microRNA for normalization. 
Results are expressed relative to mir-103a and are the mean values ± s.e.m.. B, C Oli-neu cultures 
were transfected with control-empty plasmid (pMGB) or a plasmid coding for mir-155 (pMGP155) 
and cultured for 48hr or 72hr in CM. B Cell extracts were analyzed by Western blotting for GFP, 
GPR17, SNX27 and MAG expression. Blots representative of two independent experiments are 
shown. For quantitative analyses, the signal intensity of GPR17 and MAG was standardized to the 
intensity of actin and expressed as a percentage of the amounts of proteins detected in the 48hr 
pMGB-transfected samples (control). Mean values ± s.e.m. are shown. C pMGP or pMGP155 
transfected Oli-neu cells, cultured in CM, were fixed after 48hr and doubled-immunostained for 
GPR17 and MBP. Transfected cells are identified by GFP expression. 
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DISCUSSION 
 To shed light on the mechanisms underlying GPR17 expression and function in OL 
maturation, we have recently analyzed receptor endocytic trafficking based on observations that 
receptor levels at the plasma membrane and, consequently, receptor signaling, are determined by 
the balance between receptor de novo synthesis and endocytosis (Hanyaloglu and von Zastrow, 
2008). In previous works we described that GPR17 undergoes either constitutively or agonist 
(UDP-Gluc and LTD4) -induced endocytosis. We demonstrated that GPR17 is internalized via 
clathrin-mediated endocytosis and subsequently sorted at the level of EE between two opposite 
destinies: while a portion enters the lysosomal pathway for degradation, a smaller amount is 
recycled to the plasma membrane via the Rab4-dependent recycling pathway (Fratangeli et al., 
2013). In this study, we deepen our analysis and demonstrate that GPR17 C-terminal PDZ-binding 
motif is required for receptor recycling via interaction with SNX27. This interaction mediates 
GPR17 recruitment into recycling tubules by the so called “SNX27-retromer complex” (Temkin at 
al., 2011; Gallon and Cullen, 2015). In addition, we report strong evidences that loss of SNX27 
unbalances GPR17 endosomal sorting leading to an increased receptor degradation and precocious 
down-regulation, with consequences for OL differentiation. 
 GPR17 is expressed by a specific sub-population of differentiating OPCs with a kinetics that 
is finely regulated during differentiation (Boda et al., 2011 and 2015). Its expression begins when 
OPCs exit mitosis and become cells committed to differentiation, and is sustained until OL pre-
myelinating stages. However, GPR17 down-regulation is fundamental to complete cell maturation 
(Chen et al., 2009). Such expression kinetics is in agreement with the proposed role of GPR17 as an 
intrinsic timer of OL differentiation. GPR17 expression maintains differentiating OPCs in an 
immature state until external/intrinsic signal(s) induces cells to form myelin (Chen et al., 2009). 
This function is in line with observations that OL development is a highly regulated process, 
temporally and spatially restricted, which needs to act in concert with CNS development (Mitew et 
al., 2014 and refs therein). Given these evidences, we here propose that a GPR17 increased 
degradation may be at least one of the mechanisms that underlie accelerated OL differentiation 
observed after SNX27-silencing. 
 Our results may have some implications for pathologies where OL degeneration or altered 
metabolism/development is observed (i.e. demyelinating diseases and neurological disorders; 
Fields, 2008). In this regard, it is important to note that abnormally up-regulated amounts of GPR17 
are observed in vivo in various models of neurodegenerative diseases characterized by myelin loss 
(Fumagalli et al., 2015 and refs therein). A condition that is thought to make diseases significantly 
worse by contributing to block OPC de novo differentiation and myelin repair (Hennen et al., 2013). 
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Furthermore, GPR17 was proposed to orchestrate CNS response to injuries by acting on differential 
cell types during tissue damage development and repair (Lecca et al., 2008). In addition, Viganò 
and colleagues suggested that in the adult brain GPR17 contributes to the maintenance of a reserve 
pool of committed but still undifferentiated OL precursors which is activated in response to brain 
injuries (Viganò et al., 2015). Given these observations and the extreme need for new therapeutic 
approaches for the treatment of demyelinating and ischemic/traumatic diseases of the CNS, there is 
now great interest in GPR17 as a pharmacological target and many efforts are made to establish the 
mechanisms controlling its expression (Hennen et al., 2013; Fumagalli et al., 2015). In this context, 
our data suggest that the targeting of GPR17-endosomal sorting is as a potential new therapeutic 
strategy. The pharmacological targeting of endosomal transport has been already used for the 
treatment of infections by parasites such as Plasmodium and consequent Malaria disease (van Weert 
et al., 2000). A second example is the therapeutic use of the Wnt effector Dishevelled to disrupt 
PDZ domain interactions and, consequently, Wnt signaling. An approach that was proposed for the 
treatment of prostate cancer (Grandy et al., 2009). In addition, recent evidences reporting the role of 
endosomal transport alterations in neurodegenerative disfunctions, have promoted the development 
of new biotechnological approaches (Gallon and Cullen, 2015). 
 Finally, our findings also extend knowledge on SNX27 physiological roles, showing for the 
first time that SNX27 is expressed in oligodendroglial lineage, and that has a crucial role in OL 
differentiation. 
 
SNX27 interacts with the PDZ-binding motif of GPR17 and is 
required for receptor recycling to the plasma membrane 
 We here bring many evidences sustaining the hypothesis that GPR17 C-terminal PDZ-
binding motif is required for receptor sorting into the recycling pathway. First of all, our detailed 
analysis of receptor endocytic trafficking revealed that GPR17 PDZ-binding motif integrity is 
necessary for receptor recycling. Upon transient transfection, equal amounts of wild type and 
mutant receptors were labeled at the cell surface and were internalized due to agonist stimulation, 
thus excluding alterations of biosynthesis and biosynthetic transport and clathrin mediated 
internalization. On the contrary, we found GPR17 mutants trapped in EE (Fratangeli et al., 2013) 
10min after agonist removal, thus suggesting that receptor endocytic traffic was compromised. By 
means of a Flag-tagged construct and αFLAG antibody we were able to follow GPR17-wt recycling 
to plasma membrane in live cells, a process disrupted by mutation of PDZ-binding motif. 
Quantitative analysis of wild type or mutant GPR17 demonstrated that PDZ-binding motif 
disruption determined an increase of approximately 30% of receptor retained in intracellular 
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compartments, in line with our previous data showing that after endocytosis ~30% of internalized 
GPR17 is recycled to the plasma membrane (Fratangeli et al., 2013). 
 Based on these observations, we looked for candidate partners for GPR17 among PDZ 
proteins described to regulate receptor recycling. Our studies demonstrate that SNX27 is directly 
involved in GPR17 recruitment into recycling endosomes. SNX27 is known to bind type I PDZ-
binding motifs (Rincon et al., 2007; Gallon et al., 2014). Accordingly, GPR17 C-terminal region 
directly interacts with the PDZ domain of SNX27. Two evidences support this conclusion: i) 
purified SNX27 (and not only SNX27 present in Oli-neu total protein extracts) is specifically 
isolated by the peptide containing the GPR17 PDZ-binding motif; and ii) no interaction was 
observed when a single histidine residue (H114) in the SNX27 PDZ binding groove was 
mutagenized, demonstrating that the PDZ domain of SNX27 is directly involved in mediating 
GPR17 PDZ ligand binding. 
 We next contextualized the interaction in a physiological setting by showing that GPR17 
encounters SNX27 during its endocytic transport in the endosomal compartments of Oli-neu and 
primary OLs. This occurs when GPR17 internalization is promoted by UDP-Gluc treatment as well 
as in the absence of agonist stimulation, consistent with our findings that GPR17 may undergo also 
constitutive endocytosis (Fratangeli et al., 2013). SNX27 is a cytosolic protein that is recruited to 
endosomal membranes since expresses a PX domain, which determines its affinity for PI3P-
enriched endosomal membranes (Rincon et al., 2007). In these organelles SNX27 is specifically 
localized into Rab4-positive domains due to its interaction with the retromer/WASH complexes 
(McGough et al., 2014; Lee et al., 2016). Consistently, GPR17 was also shown to traffic through 
Rab4-positive compartments (Fratangeli et al., 2013). 
 
 Loss of SNX27 affects GPR17 recycling, leading to retention of receptor into endosomal 
compartments. Accordingly with data showing that prolonged retention in the EE favors protein 
cargo delivery to degradative compartments (note that EE undergo a constant process of remodeling 
and maturation, Scott et al., 2014), we demonstrated that the levels of endogenous GPR17 are 
significantly reduced in Oli-neu after SNX27 silencing. Remarkably, shRNA-SNX27 transfection 
does not alter the expression of either proteins involved in the correct functioning of intracellular 
trafficking (actin) or proteins that do not depend on SNX27 for their recycling (cadherins), thus 
showing that shRNA-SNX27 specifically targets SNX27. Our data also prove that GPR17 
undergoes to partial lysosomal degradation in SNX27-silenced Oli-neu. However, on the basis of 
the partial recovery of GPR17 expression upon lysosomal inhibition we speculate that GPR17 
enters other degradative pathways, for example proteasomes. In this context, it is interesting to note 
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that Wang and colleagues, showed that AMPA and NMDA receptor degradation after SNX27 
silencing is rescued by both lysosomal and proteasomal inhibitors (Wang et al, 2013). 
 Finally, we can also conclude that SNX27 is indeed responsible of correct GPR17 recycling, 
since receptor levels are partially rescued when SNX27-silenced Oli-neu (mouse) are co-transfected 
with a shRNA-insensitive SNX27 isoform (human-SNX27). The partial recovery of GPR17 levels 
may be due i) either to a different affinity of human-SNX27 for murine GPR17 ii) or to interference 
of SNX27-overexpression with endocytic homeostasis, as already described by other groups 
(Lauffer et al, 2010; Munoz and Slesinger, 2014). 
 
 In conclusion we have demonstrated that after endocytosis GPR17 can be recycled at the 
cell surface via interaction with SNX27-retromer complex. Inhibition of the pathway determines the 
premature down-regulation of the receptor. 
 
Loss of SNX27 accelerates OL differentiation kinetics 
 SNX27 down-regulation results in an accelerated maturation of differentiating OLs, an 
effect that we propose to be mediated, at least in part, by GPR17 precocious down-regulation. 
 OL differentiation, altered by SNX27/GPR17 down-regulation, seems to concern mainly the 
kinetics of the process. The synthesis of myelin proteins, at least in OL cultures, is not altered but 
only early, and OLs do not exhibit apparent defects in maturation. In addition, SNX27 silencing per 
se is not sufficient to trigger proliferating OPCs (i.e. Oli-neu cultured in Sato medium) towards a 
pro-differentiating condition (data not shown), meaning that a different stimulus is required to 
initiate differentiation process and/or that SNX27 exerts its effects by acting on target proteins that 
are expressed during OL differentiation but absent in immature OPCs. Our data are consistent i) 
with the role of GPR17 as “intrinsic timer” of OL maturation (Chen et al., 2009) and ii) with the 
kinetics of GPR17-expression in OL development (Boda et al., 2011; Fratangeli et al., 2013). 
Remarkably, GPR17 decrease after SNX27-silencing is accompanied by increased translocation of 
Id2 from nucleus to cytosol, in line with results by Chen and colleagues, who proposed Id2 as one 
of the effectors acting downstream of GPR17 activation (Chen et al., 2009). Id2 is a known 
inhibitor of OL differentiation that accumulates in the nucleus and sequesters OLIG2 TF, thus 
hampering pre-myelinating cells to express MAG and MBP myelin proteins (Chen et al., 2009). 
 Despite the data suggesting that SNX27 alters OL development by regulating GPR17 
recycling, we cannot exclude that other molecules may be involved. SNX27 has been described in 
HeLa cells to regulate the trafficking of approximately hundred different cargos and is considered a 
general hub regulating the recruitment of cargos that express a type I PDZ-binding motif and that 
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requires retromer complexes to recycle via the fast pathway (Steinberg et al., 2013). Some SNX27-
regulated cargos are known to be expressed by OLs. AMPA and NMDA receptors, for example, are 
expressed, though at low levels, in OL lineage (Hossain et al., 2014; Li et al., 2013). However, it is 
important to note that their roles in OL differentiation are still controversial with contradictory 
results reported in particular between in vivo and in vitro studies (Emery, 2010). 
 An accurate endosomal sorting has relevant implications for development as shown in other 
cell lines and tissues. An example is the Frizzled alternative degradation or retrograde transport 
upon Wnt-induced endocytosis. When the balance between these two pathways is compromised 
embryonic development alternations have been observed (Seto and Bellen, 2006; Yu et al., 2007). A 
second example is the lysosomal-mediated down-regulation of erythropoietin receptor, which is a 
prerequisite to allow erythrocyte precursors complete maturation (Walrafen et al., 2005). On the 
basis of the observation of the dramatic effects of its knockout, it has been proposed that also 
SNX27 is required for the correct development of many different tissues: SNX27 deficient mice 
exhibit severe growth retardation and die within few weeks after birth (Cai et al., 2011). 
 Taken together, our data highlight the importance of SNX27 expression for OL 
differentiation via mechanisms that include the regulation of GPR17 recycling. It would be 
important to reveal whether SNX27 expression decreases during OL maturation in parallel with 
GPR17 down-regulation, thus further supporting its physiological role in GPR17 expression. 
Unfortunately, we still have not answered this question. Our preliminary data in Oli-neu suggested 
that SNX27 expression does not undergo to significant changes during cell differentiation (data not 
shown). However, online databases reporting gene expression profiling during OL development 
show that SNX27 transcription is reduced during the differentiation progression (Zhang et al., 
2014), in line with the requirement of promoting GPR17 degradation when immature OLs enter 
terminal maturation. Moreover a recent work by Tian and colleagues has reported that arrestin 
domain-containing protein 3 (ARRDC3) competes with SNX27 for β2AR engagement and 
negatively regulates receptor entrance into recycling tubules, with the final result of maintaining 
β2AR in the EE for a prolonged period (Tian et al., 2016). Interestingly, ARRDC3 transcript 
increases during OL maturation (Marques et al., 2016), raising the possibility that ARRDC3 
competition with SNX27 may contribute to GPR17 down-regulation. 
 
OL development in SNX27-deficient Ts65Dn brains 
 Since SNX27 expression may be involved in OL differentiation we considered the 
possibility of a disregulation of OL differentiation in pathological conditions characterized by 
altered levels of SNX27. A growing number of data indicate that alterations of retromer complex 
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components (i.e. VPS26 and VPS35 as well as SNX27) are associated to the pathogenesis of some 
neurodegenerative conditions. With regards to the retromer, it has been shown that in line with its 
function in the retrograde transport of amyloid precursor protein (APP), reduced levels of 
expression of both VPS26 and VPS35 subunits are present in brain areas vulnerable to Alzheimer’s 
disease (Small et al., 2005). In addition, mutations that disrupt VPS35 interaction with WASH 
complex were shown to be risk factors for the pathogenesis of Parkinson’s disease (Vilariño-Güel et 
al., 2011; Zimprich et al., 2011). A mutation/deletion in SNX27 human gene on the other hand, has 
recently been reported and associated to a familiar form of infantile myoclonic epilepsy and 
neurodegeneration (Damseh et al., 2015). Finally, recent observations have shown that SNX27 
deficiency contributes to cognitive impairment in DS patients by altering the expression of AMPA 
and NMDA receptors in hippocampal neuron synapses (Wang et al., 2013). On the basis of this 
observation and our previous data, we investigated OL differentiation in trisomic brains. Using 
Ts65Dn mouse model of DS, we show alterations in the number of pre-myelinating/mature OLs in 
different brain regions of trisomic mice. In spite of an overall increase in OLIG2-expressing cells, 
which suggests an higher number of OLs in Ts65Dn mice brains than in euploids, we report that the 
number of GPR17-expressing cells are reduced, whereas the number of CC1-positive cells (mature, 
but not myelinating OLs; Boda et al., 2011; Viganò et al., 2016) is increased. These results are 
consistent with our in vitro findings, indicating a correlation between OL accelerated maturation 
and GPR17 down-regulation in a context of reduced SNX27 expression. Despite these observations, 
and in accordance with the condition observed in trisomic brains (Abraham et al., 2012), hypo- and 
not hyper-myelination was found in Ts65Dn brains, as revealed by immunochemistry and 
immunoblotting analyses of MBP. This result seems to contradict our in vitro findings that indicate 
an accelerated OL differentiation with any defects in myelin protein synthesis. However, it has been 
reported that DS brains are characterized by a reduced number of neurons (Contestabile et al., 2007; 
Guidi et al., 2008; Guidi et al., 2014). Thus, it can be hypothesized that the defects in myelin 
formation (despite the accelerated maturation of OLs) may be due to the presence of a reduced 
number of axonal targets. 
 A thorough analysis would be required to contextualize our results in the complex scenario 
that DS pathogenesis implies. DS is a highly complex pathological condition, with different factors 
involved. In this context it is important to note that recent data from Olmos–Serrano and 
collaborators demonstrate the presence of myelin defects in DS brain (in line with our results) but 
suggest that these defects may depend on cell autonomous mechanisms related to an altered 
expression pattern of a cluster of genes required for OPC maturation (Olmos-Serrano et al., 2016). 
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mir-155 up-regulation inhibits OL differentiation 
 To gain more insights in the complexity of OL degeneration in DS, we decided to extend our 
analysis on the molecular mechanisms underlying SNX27 down-regulation. As reported by Wang 
and colleagues SNX27 deficit depends on the down-regulation of C/EBPβ TF which is inhibited by 
the trisomy-linked overexpression of mir-155 (Wang et al., 2013). In line with previous data (Leong 
et al., 2014) we demonstrated that mir-155 is expressed in oligodendroglial lineage, though at very 
low levels. This result prompted us to test in vitro the effects of mir-155 overexpression using Oli-
neu, thus mimicking DS condition. Mir-155 overexpression determines a strong inhibition of OPC 
differentiation (in line with data of Olmos-Serrano and colleagues, 2016) that finally results in a 
decreased expression of both GPR17 and myelin proteins, MAG and MBP. In addition, mir-155 
overexpression seems to exert an effect also on undifferentiated Oli-neu, leading to a morphological 
change that resembles that of differentiating cells but without reaching a mature state, since markers 
of differentiating phases are not expressed (data not shown). On the other hand, transfected cells 
retain expression of the OPC markers (OLIG2 and NG2) and do not express markers of different 
lineage (i.e. GFAP) suggesting that they maintain their lineage specification (data not shown). 
 Apparently, we did not observe a significant decrease of the SNX27 levels  in Oli-neu 
(reduction of approximately 10%) upon overexpression of mir-155. Further experiments are needed 
to confirm the result and to understand the reasons. One possible explanation is that C/EBPβ TF is 
expressed in a very low amount in oligodendroglial lineage cells, as reported by different online 
databases of gene expression profile during OL differentiation (Zhang et la., 2014; Marques et al., 
2016), suggesting that in OLs SNX27 expression may be regulated by different TFs, not affected by 
mir-155. This partially explains the discrepancy observed between the effects of mir-155 
overexpression and the accelerated OL maturation that results from SNX27 silencing. 
 
 In the light of these data, we planned to identify mir-155 targets in OLs responsible for the 
observed effects. To this aim we took advantage of miRTarBase online database 
(http://mirtarbase.mbc.nctu.edu.tw/) to obtain a list of all validated targets of human and murine 
mir-155. After removal of targets with weak functional evidences, we classified the remaining on 
the basis of i) their expression during OL differentiation (performed using the mentioned online 
databases; Zhang et al., 2014; Marques et al., 2016); ii) the number of references reporting their 
targeting by mir-155 (used as a criterion to assess the strength of the datum); iii) the expression 
profile in DS brains (used as a criterion for putative functional correlations), performed using the 
online database generated by Olmos-Serrano and colleagues (Olmos-Serrano et al., 2016); iv) 
literature evidences reporting associations with OLs. 
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 The result of this in silico analysis was the identification of 15 mir-155 targets (Table 3) that 
have a well-established association to mir-155 and an expression profile that correlates with 
putative roles in mediating the pathological effects of mir-155 up-regulation in DS brain. Some of 
these targets will undergo to experimental validation in order to understand their possible 





Our study of the molecular mechanisms underlying GPR17 intracellular trafficking 
demonstrates a new role for SNX27 in the regulation of GPR17 recycling and in OL differentiation. 
SNX27 is a well-described mediator of receptor sorting into the fast recycling pathway, but had 
never been described in OLs. We show that by direct binding with GPR17 PDZ-binding motif, 
SNX27 prevents receptor degradation, thus contributing to maintain correct levels of GPR17 
expression, which is a crucial requisite for OL correct kinetics of differentiation. Furthermore, we 
described altered OL differentiation and myelin defects in Ts65Dn brain, which correlates with that 
observed in human DS patients. This suggests that in addition to the well-characterized impairments 
in neuronal functions, other defects (for example in myelination) may be involved in the 
pathogenesis of the cognitive deficits that characterize DS. We also propose that up-regulation of 
mir-155 may be involved not only in neuronal defects (Wang et al., 2013), but also in inhibition of 
OL maturation and hypomyelination found in trisomic brains. We now propose a list of putative 
new targets, beside C/EBPβ / SNX27, that could be used as a starting point to understand mir-155 
pathological functions. 
 These results, apart from contributing to better understand GPR17 and SNX27 physiological 
functions, deepen our knowledge on the mechanisms that control OL differentiation, and may serve 
for a better understanding of pathological conditions characterized by myelin degeneration or OL 
differentiation impairment. Finally, we hope they could be exploited for the development of new 
strategies to promote myelination repair in demyelinating and neurological diseases. 
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Raised in rabbit  
(Fratangeli et al., 2013) 
Western blotting (dilution 1.75 µg/µL), 
immunofluorescence, (dilution 10 µg/µL) and 




Raised in rabbit  
(Fratangeli et al., 2013) 




Merck Millipore (Billerica, 
MA) 
Western blotting (dilution 1:1,000) and 
immunofluorescence (dilution 1:200) 
Flag tag – 
monoclonal  
Merck Millipore (Billerica, 
MA) 
Immunofluorescence of live cells (dilution 1:150) and 
fixed samples (dilution 1:250) 
Myc tag – 
monoclonal  
Sigma-Aldrich (Milan, IT) Western blotting (dilution 1:500) and 
immunofluorescence (dilution 1:300) 
MBP – monoclonal  Covance (Milan, IT) Immunoflourescence (dilution 1:500)  
MBP – monoclonal Merck Millipore 
(Temecula, CA) 
Western blotting (dilution 1:2,000) 
TfR – monoclonal  Life Technologies (Monza, 
IT) 
Western blotting (dilution 1:1,000) and 
immunofluorescence (dilution 1:100) 
GFP – polyclonal  Merck Millipore (Billerica, 
MA) 
Western blotting (dilution 1:2,000) 
Pan cadherin – 
monoclonal  
Sigma-Aldrich (Milan, IT) Western blotting (dilution 1:1,000) and 





Western blotting (dilution 1:1,000) 
NG2 – polyclonal Merck Millipore 
(Temecula, CA) 





Western blotting (dilution 1:1,000) and 
immunofluorescence (dilution 1:100) 
SNX27 – 
polyclonal 
Raised in goat. Santa Cruz 
Biotechnology (Dallas, 
TX) 
Immunofluorescence (dilution 1:400) 
Actin - monoclonal Sigma-Aldrich (Milan, IT) Western blotting (dilution 1:1,000) 
GS28 - monoclonal Enzo Life Science (Italy) Western blotting (dilution 1:1,000) 
Olig2 – polyclonal  Merck Millipore (Billerica, 
MA) 
Immunohistochemistry (dilution 1:200) and 
immunofluorescence (dilution 1:150) 
CC1 – monoclonal  Merck Millipore (Billerica, 
MA) 
Immunohistochemistry (dilution 1:50) 
Id2 – polyclonal Santa Cruz Biotechnology 
(Dallas, TX) 
Western blotting (dilution 1:400) 
GAPDH – 
monoclonal 
Santa Cruz Biotechnology 
(Dallas, TX) 
Western blotting (dilution 1:500) 
α-tubulin – 
monoclonal 
Sigma-Aldrich (Milan, IT) Western blotting (dilution 1:1,500) 
GRK2 – polyclonal Santa Cruz Biotechnology 
(Dallas, TX) 
Western blotting (dilution 1:200) 
mTOR – 
monoclonal 
Cell Signaling (Danvers, 
MA) 
Western blotting (dilution 1:1,000) 
Phospho-mTOR – 
monoclonal 
Cell Signaling (Danvers, 
MA) 
Western blotting (dilution 1:500) 
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Table 2. GPR17 PDZ-binding motif mutants used in the study. 
 
Name Sequence 
mGPR17-wt ATG […]AGT.GCC.CGA.TCC.GAG.CTG.TGA 
NH […]   S       A       R       S       E       L       * 
mGPR17-SELA ATG […]AGT.GCC.CGA.TCC.GAG.CTG.GCA.TAA 
NH […]   S       A       R       S       E       L       A       * 
FLAG-hGPR17-wt ATG […]AGT.GCC.AAG.TCA.GAG.CTG.TGA 
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Table 3. Putative mir-155 targets in OL differentiation (GO was based on NCBI 
database updated at the 26th of November 2016; in bold are DEX genes from the database of 
Olmos-Serrano and colleagues, 2016). 
 
Gene Name Gene Onthology Species 
OPCs 
SOCS1 Insulin-like growth factor receptor binding; kinase inhibitor activity; 
negative regulator of JAK-STAT cascade 
Mouse and 
Human 
HIVEP2  DNA binding; metal ion binding; multicellular organism development; 
regulation of transcription 
Human  
MASTL ATP binding; protein phosphatase 2A binding; protein serine/threonine 
kinase activity; G2/M transition of mitotic cells; cell division 
Human 
TAF5L  Contributes to histone acetyltransferase activity; transcription 
coactivator activity; histone H3 acetylation 
Human 
TLE4  Chromatin binding; transcription factor activity; Wnt signaling 
pathway 
Human 
TRAK1  GABA receptor binding; endosome to lysosome transport; protein O-
linked glycosylation 
Human 
NFOs (Newly Forming Oligodendrocytes) 
LRRC9  NAD+ ADP rybosyltransferase activity Human 
MFOs (Myelin Forming Oligodendrocytes) 
FAM135A Carboxylic ester hydrolase activity; cellular lipid metabolic process Human 
MEF2A  RNA polymerase II core promoter proximal region sequence-specific 
DNA binding; RNA polymerase II transcription factor binding; ERK5 
cascade 
Human 
MEIS1  RNA polymerase II core promoter proximal region sequence-specific 
DNA binding; chromatin binding; angiogenesis 
Human 
PCDH9 Calcium ion binding; forebrain development; cell-cell contact zone Human 
PHC2 DNA binding; multicellular organism development; PRC1 complex Human 
RAB11FIP2 RabGTPase binding; establishment of cell polarity; insulin secretion 
involved in cellular response to glucose stimulus; regulated exocytosis 
Human 
SECISBP2 mRNA 3’-UTR binding; poly(A) RNA binding; negative regulator of 
nuclear-transcribed mRNA catabolic process, nonsense-mediated 
decay; neuron development 
Human  
MOs (Myelinating Oligodendrocytes) 
CEP41 G2/M transition of mitotic cell cycle; cell surface; cell-cell junction; 
centriole 
Human 
 
 
 
